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ABSTRACT 
Monitoring the Adaptation to Experimental Pain Using Functional Near Infrared 
Spectroscopy 
By: Daryl Omire-Mayor 
 
Background: Despite pain being one of the more thoroughly studied phenomena, it is still 
one of the more complex and least well understood.  Studies of late, in particular imaging studies, 
have made an attempt to take individuals’ subjective response to pain into consideration, while 
observing how their bodies respond physiologically.  This has led to our lab’s focus on the 
adaptation to pain.  As adaptation is the reduction of the response to a given stimulus over time, 
monitoring the adaptation to experimental pain over time using functional near infrared 
spectroscopy shows the change in autonomic response with each additional exposure.  Doing this, 
while also observing the change in perception to each additional exposure, can further progress the 
research of pain imaging, and more importantly, show how changes in physiological response and 
perceptive response correlate over time.  
Methods: In the investigations outlined in the aims of this thesis, experimental pain (the 
cold pressor test in a repeated-measures fashion) was used to conduct experiments in healthy 
subjects.  In conjunction with this, the McGill Pain Questionnaire and State Trait Anxiety 
Inventory were employed during experimentation as well.  In post experimentation analysis, 
multilevel modeling, linear regression and clustering were the main techniques used to understand 
how the pain response changes with each additional exposure to a stimulus. 
Results: These statistical techniques yielded results that suggest that with each additional 
exposure to noxious stimulus, the magnitude of a subjects’ autonomic response continues to 
diminish.  Through the measures of perception, the subjects did not show significant change with 
each additional exposure; although, there was a trend demonstrating that the subjects felt the pain 
with slightly less intensity with each additional exposure. 
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Conclusions: From interpreting the results of the studies performed as a part of this thesis, 
it is evident that functional near infrared spectroscopy is a powerful enough imaging tool to 
monitor adaptation to repeated exposure of stimuli.  To further understand how perception and 
autonomic response relate, more studies with a greater number of subjects will give greater 
understanding of the connection (or lack thereof) between the two. 
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Chapter 1 
 
1.1 Background 
 
Pain is a complicated phenomenon in that it is necessary because it gives the body 
awareness of when it is danger, or any state that deviates from stable and requires correction.  Even 
further, acute pain is adaptive and results in survival actions being taken such as escaping 
behaviors.  In contrast, chronic pain is maladaptive causing suffering and a great reduction in life 
expectancy (Diatchenko, Nackley, Tchivileva, Shabalina, & Maixner, 2007).  The issue with pain 
in general is that the human pain conditions present in a multitude of biological and psychological 
phenotypes, in particular, in idiopathic pain disorders.  Environmental events that invoke tissue 
injury and psychological distress also add to the difficulty for diagnosis, due to the way that they 
can influence amplification of the way that pain is experienced. 
Recently, there has been increased interest in the role of both sodium channels and calcium 
channels as mechanisms behind the development of pain, specifically chronic pain.  Voltage-gated 
sodium channels (VGSC), post nerve injury, have been proven to show changes in plasticity after 
nerve injury through their expression.  Both Nav 1.7 (SCN9A gene) and Nav 1.8 (SCN10A gene) 
(sodium ion channels that are expressed at high levels in nociceptive neurons) have been linked 
with excitability, as well as increased transmission of nociception (pain).  Nav 1.7 has even been 
said to show genetic linkage when it comes to certain pain diseases (Diatchenko et al., 
2007). These sodium channels play an important role as damage to them sheds light onto their 
central activity, as it ultimately can lead to things such as allodynia and hyperalgesia. (Dickenson, 
2011; Phillips, Drevets, Rauch, & Lane, 2003) 
Calcium channels, in a similar fashion as sodium channels, take part in neuronal excitement 
(Dickenson, 2011).  What calcium channels do is allow for the neurotransmitter release from the 
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central terminals to the spinal neurons (Dickenson, 2011). This interplay leads to activation of the 
sensory signals in the CNS.  The problem with pain comes in when looking at the major transmitter 
receptors, such as the N-methyl-D-aspartate (NMDA) receptor for glutamate.  It is the constant 
firing at these receptors that leads to chronic pain, and similar pain related issues when dealing 
with other diseases.  This is the reason why most medications or treatments for pain involve 
antagonists to receptor sites on the NMDA receptor complex and similar receptors. (Chambers et 
al., 1999; Ledoux, 2000) 
Recall that NMDA receptors are trans-membrane receptors. An ion channel starts off with 
a magnesium plug.  When you get the nociceptive stimulus that comes in, glutamate initially 
releases the magnesium plug from the central core of the NMDA receptor.  Following that, 
glutamate and glycine and other pro and anti-inflammatory pain mediators can influence the 
NMDA receptors while glutamate binds intimately with the NMDA receptor. This allows calcium, 
sodium and sometimes potassium to flow through the necessary channels and ultimately leads to 
post-synaptic changes that result from pain caused by nerve damage. (Dickenson, 2011) 
To corroborate this finding of NMDA, a study was conducted by Nair et. al to look at the 
elevation of glucocorticoids due to stress and how this increases the proliferation of microglia 
through NMDA receptor activation.  This study used physiological stress to increase the 
corticosterone level in mice CNS. The stress induced proliferation of microglia as a function of 
NMDA receptor stimulation; however, blockage of the NMDA receptor prevented stimulation of 
the microglia, thus demonstrating that the ability of drugs, such as NMDA receptor antagonists, to 
affect NMDA, can have a significant effect of stress processing and microglia (reticuloendothelial 
system) stimulation. (Nair & Bonneau, 2006) 
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When taking a more in depth look at how noxious stimuli is processed, we see that there is 
a much bigger and more complex picture than only looking at the NMDA receptor.  First, we start 
in the periphery, with an injury. This injury can be the result of direct trauma, vascular damage, 
direct skin trauma, damage to the neuron itself, the primary afferent neuron injury, etc.  This injury 
leads to a release of neuronal and non-neuronal ligands. These ligands in the primary afferent 
neuron (PAN) include Substance P, CCK, ATP, glutamate and many others.  Some non-neuronal 
ligands include acetylcholine, amino acids (glutamate), cytokines and opioids, as well as many 
others.  These ligands have a number of effects on receptors on primary afferent neurons and 
various other afferent neurons. The transducer channels that help to advance this signal include the 
sodium and calcium channels, as well as acid-sensing ion channels (hydrogen channels) and 
potassium channels and a few others, all of which begin the initial processing of the nociceptor 
transmission.  The receptors themselves on the PAN that act in the initial response to the trauma 
are bradykinin, histamine, serotonin, protease, etc. These are all a part of generating the initial 
inflammatory reaction that occurs peripherally after a pain experience. (Rainville, 2002) 
After the initial observation of noxious stimuli, the PAN sets up the nociceptive signal. A-
delta and C fibers access higher order neurons by synapse. This occurs in the superficial layers of 
the dorsal horn gray matter. In this superficial layer, the area of focus is the rexed laminae, in 
particular, the substantia gelatinosa. A-delta and C fibers synapse high up in rexed laminae, 
whereas the A-beta fibers synapse deeper. This is first order to the second order of neurons.  This 
synapse in the dorsal horn is an extremely pivotal area in pain signaling upwards and downwards 
as well. The signal comes towards the end of the PAN and at that synapse, there is a release of pro-
nociceptive substances, more importantly substance P and glutamate. At the same time in the pre-
synaptic membranes, not only are there pro-pain neurotransmitters and inflammatory mediators, 
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but also there are anti-pain modulators as well such as GABA, glycine, serotonin, noradrenaline 
and endogenous opioids which are important in this area. The main central post-synaptic receptor 
in transmission of pain fibers is the NMDA receptors. (Rainville, 2002) 
The post-synaptic changes that occur essentially are the systems that are activated to set up 
second messengers, which leads to an influx in calcium by way of a number of mechanisms. The 
IP3 mechanisms, PKC, PKA, etc.  All of these mechanisms give rise to the influx of calcium, 
which ultimately leads to membrane hyperpolariziation and continuation of the neurotransmission 
of pain. On the postsynaptic side, there are important receptors and channels, gaba, delta and mu 
opiate receptors, etc. where analgesic efforts can be focused. Gaba A and gaba B receptors, NMDA 
receptors, opioid receptors will all aid in the effort of finding ways to relieve pain.  In addition 
there are alpha-2 and NK1 receptors, but these are outside of the scope of this paper. (Rainville, 
2002) 
After the second order neurons, the pain pathways need to get up to the higher centers of 
the brain, so they need to travel in multiple ascending tracts. The ascending spinal tracts are 
spinaothalamic, tracts which act as a mediator to the experience of sensations, spinoreticular tracts 
which responds to noxious stimuli and provide signals to the autonomic centers in the brainstem, 
spinomesencephalic,  which associates itself with the periaqueductal grey matter (PAG) and has 
neurons that respond to noxious or innocuous stimuli, and spinoparabrachial tracts that have an 
effect on autonomic changes and emotions in pain, and are primarily involved in nociceptive 
activity. Once the pain signal reaches the thalamus mid-brain, higher supraspnial projections occur, 
and from there, the spinothalamic region projects the signal out to the cortical areas and the 
somatosensory cortices, S1, S2, ACC, PFC, and the insula. Spinoparabrachial tracts project to the 
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thalamus and amygdala, and the spinomesencephalic region projects to the PAG and reticular 
activating system, which can add to the excitement resulting from noxious inputs. (Rainville, 2002) 
These higher centers help to form what Melzack termed as the pain matrix. It is not simply 
a group of areas in the brain that are linked together.  It should be thought of as something that is 
fluid and unique to each individual, as we all have different specificities when it comes to our pain 
matrix (cortical areas: sensory cortices S1 and S2, the anterior cingulate cortex, the prefrontal 
cortex, and the insula; subcortical areas: thalamus, amygdala, hippocampus, basal ganglia). This 
is a great topic of interest particularly now with advances in brain imaging as these areas can be 
monitored over time. (R Melzack, 2001) 
The descending pathways of pain include the PAG, which deals with the release of opioids, 
the nucleus raphe magnus, which releases serotonin, the locus ceruleus which releases 
noradrenaline, and lastly the rostroventral medial medulla which leads to the last part of the 
descending pathway, the serotonergic facilitatory pathway that terminates in the spinal cord.  It 
makes sense to say that the activity surrounding these descending pathways increases post-injury 
as that is when the ascending and descending pathways come into play; however, when things such 
as fear and anxiety accompany pain, they (at times) amplify this pain due to the link the pathways 
have between the emotional states and pain level.  Because these descending facilitators are 
independent of long-term potentiation (LTP: an extended time-period where synapses between 
nerve cells are strengthened) and the initial pain response, they add to the complexity of pain and 
its intensity. When thinking of both the ascending and descending pathways in conjunction with 
one another, the gate control theory gives a big picture idea of pain processing. (Dickenson, 2011)   
Interpreting the ascending and descending pathways of pain gives a very holistic picture to 
the bodies response to pain; however, missing from this description of the physiological response 
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to pain, is the subjective perceived response to pain.  This is subject to several environmental 
factors that are not standardly experienced by every individual, and warrants further investigation 
when seeking to understand pain in full. 
The Cognitive-Emotive Dimensions of Pain Perception 
Emotional perception includes three processes that follow the presentation of an emotive 
stimulus (Goldstein  N., 2002; Phillips et al., 2003).  First, the stimulus is identified and evaluated 
for its emotional significance. Subsequently, affective states are generated in response to the 
stimulus. These affective states involve both autonomic, neuroendocrine, and somatomotor (e.g. 
facial, gestural, vocal, and behavioral) responses and conscious emotions. These emotions can then 
influence the initial identification and evaluation of emotional stimuli. A third process follows in 
which the affective state and emotional behavior are regulated per contextual data and often by 
means of inhibition and modulation of the first two processes. 
Physiological feedback measured from the central and peripheral nervous system was first 
used to assess the emotional perception of painful stimuli; however, researchers could not discern 
between the emotive stimulus and the subsequent affective state (Phillips et al., 2003). Instead, 
animal and human studies have identified neural regions associated with the identification and 
neurobiological response to emotive stimuli.  The regions of the brain that aid in the identification 
of external stimuli, the production of the following affective states, and the mediation of autonomic 
responses to external stimuli are: the ventral system, amygdala, insula, ventral striatum, and ventral 
regions of the anterior cingulate gyrus and prefrontal cortex (Phillips et al., 2003). The amygdala 
appears to be associated with the emotional perception of facial expression and gaze.  Furthermore, 
evidence indicates the role of the insula – a network including the ventromedial prefrontal cortex, 
amygdala, hypothalamus and periaqueductal gray – in the orchestration of autonomic responses to 
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stimuli identified and evaluated as threatening.  Studies in humans with focal brain lesions 
corroborate these findings (Phillips et al., 2003). The dorsal system, including the hippocampus, 
the dorsal anterior cingulate gyrus, and the prefrontal cortex integrate cognitive processes with 
emotional information. These brain regions are also associated with executive functions such as 
selective attention, planning, and conscious regulation of affective states (Phillips et al., 2003). 
Given the level of regulation of these affective states, it would appear that great insight into 
what pain is has been observed; however, the subjectivity of it has not been addressed.  The reason 
it is essential to look at perception on a subjective basis is because individuals can, in a sense, 
control the way that they perceive things.  This leads into perceived controllability, which is the 
notion that those who believe that they can control an aversive event from taking place, show less 
autonomic arousal and focused impairment than those who do not believe that they can control the 
occurrence of said aversive event, although both groups remain vulnerable to the same stimuli. 
(Bandura & Wood, 1989)   
An additional category of pain that can lead to less autonomic arousal is pain adaptation.  
Adaptation can be defined as a reduction in response to repeated exposure to a given stimuli.  In 
the case of repeated exposure, while the perception of pain may change, the external stimuli itself 
does not necessarily change.  What this means is that the body still must react appropriately to 
stimuli.  Due to this autonomic response based on environmental factors, several brain imaging 
techniques have emerged as being potentially useful in understanding pain by investigating the 
correlation of an autonomic response to external factors, and how it relates to perception (Bandura 
& Wood, 1989; Salomons & Johnstone, 2007).  Conducting a study on pain adaptation would yield 
greater understanding of the reciprocity between pain perception and the physiological response. 
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1.2 Pain Adaptation and Problem Statement 
 
Adaptation to pain is a defense mechanism in which the body aims to reduce the amount 
of pain caused to the body as a result of a given stimulus (Hodges & Tucker, 2011). This involves 
several different bodily reactions that can occur individually or in conjunction with one another: 
(1) the activity within or between the muscles engaged as a results of the stimulus is redistributed, 
(2) mechanical behavior is also modified (this is seen as stiffness or change in movement, (3) the 
previous two resulting in the body protecting itself from further pain/injury, (4) changes from (2) 
occur at multiple levels of the motor system and are not restricted to one area, (5) in the short term 
this is greatly beneficial; however, in the long term, it is not ideal to remain in a situation where 
the body is forced to adapt to pain, given the adjustments that the body makes seen in (1) and (2) 
(Hodges & Tucker, 2011). Due to the amount of bodily changes that occur because of adaptation, 
further understanding how the body adapts to pain can give great insight into how one experiences 
pain.  From this motivation stems the focus of this thesis: to Monitor and evaluate the effects of 
repeated exposure to experimental pain (both noxious and innocuous stimuli) on the 
hemodynamic response, using functional near infrared spectroscopy.  Noxious stimuli can be 
defined as a generally painful stimulus, while innocuous stimuli can be thought of as a stimulus 
that is generally not painful. 
 
1.3 Objectives 
 
The primary purpose of this PhD research is to monitor the fNIRS signal over time for an 
objective assessment of adaptation to pain. 
Given the flexibility and usability of fNIRS, we plan to take advantage of this and pursue 
the monitoring of this signal in the assessment of the adaptation to pain.  Further, we look at 
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subjective measures of pain to compare to the signal, to ensure that the objective measure considers 
the subjective nature of pain.  The goal of this research is to assess the usability of fNIRS 
measurements, as a monitor of adaptation to stimuli over time with fNIRS.  This will be done by 
visualizing the changes to the hemodynamic response over time in the prefrontal cortex regions. 
 
1.4 Specific Aims and Research Hypotheses 
 
SPECIFIC AIM 1. fNIRS and Adaptation. The goal of this specific aim is to measure 
adaptation to noxious and innocuous (non-painful) stimuli (with the cold pressor test at 4°C and 
15°C respectively) through measurements from the fNIRS signal.  Within this aim, we first want 
to identify whether adaptation is observable by the fNIRS system.  Looking at features 
(identified from previous work) of the fNIRS signal across multiple trials after repeated 
measures testing, we will see if trends of adaptation occur.  The hypothesis here is that 
adaptation will show through a diminished response over time.  The second part of this aim 
would include comparing noxious stimuli to innocuous stimuli (4°C cold pressor test and 15°C 
cold pressor test).  15°C was used as the innocuous stimuli as this is CPT level is general 
considered non-painful.  We hypothesize that adaptation will not look the same in both cases, but 
rather that in the case of 4°C, adaptation will be clearer than the adaptation observed in 15°C (if 
adaptation occurs at all at this temperature).    With these two points of focus, we will gain initial 
insight into how the hemodynamic response changes over time with repeated exposure to stimuli.   
SPECIFIC AIM 2. Perception of Pain and Adaptation.  In this aim, we want to look 
specifically at the relationship between the perceived adaptation to pain and the fNIRS signal.  
This will be done through the comparison of the signal features that were deemed significant 
(based on channel and chromophore; Oxyhemoglobin: HBO2 or Deoxyhemoglobin: HB) in AIM 
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1 and two psychological measures.  The first of which is Short-Form McGill Pain Questionnaire, 
which includes the visual analogue scale (Kabat-Zinn, 1982; R Melzack, 1987, 2001; Ronald 
Melzack & Wall, 1996). This is a survey created by Robert Melzack that is widely used in pain 
medicine and research to better understand patients pain experiences.  The second is the State 
Trait Anxiety Inventory (Spielberger  R.; Lushere, R., 1971).  This inventory, which is measured 
before and after experimental sessions with repeated exposure to stimuli, will give us a measure 
of subjects’ anxiety before and after pain testing to see if there is a significant change or trend in 
anxiety, as well as if it correlates to the changes in the fNIRS signal.  In particular, the focus will 
be on state anxiety because that is indicative of present anxiety level, versus trait anxiety which 
relates more to a generalized anxiety experienced by an individual outside of the present state 
(Spielberger  R.; Lushere, R., 1971).  We hypothesize that there will be a correlation between 
perception and the hemodynamic response seen in the fNIRS signal.  The evaluation of the 
hemodynamic response in this aim will show if the change in the hemodynamic response seen in 
AIM 1, has a strong relationship with the way that pain is perceived by subjects. 
SPECIFIC AIM 3. Exploratory Analysis of fNIRS Clustering in Adaptation.  The intention 
behind this aim is to see if the fNIRS data can be grouped based on trial number of the repeated 
measure experimentation (i.e. does the data from the first trial look different from the data in the 
last trial).    This will be done using the unsupervised machine learning technique of clustering, 
and we hypothesize that earlier trials will be easily differentiated from the later trials through 
clustering.  If clustering can differentiate between trials undergone by subjects based on the 
hemodynamic response data, this will suggest that the fNIRS system is sensitive enough to 
observe a reduction in response to stimuli (adaptation) over time through monitoring repeated 
exposure to stimuli.  
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1.5 Advancements in Pain Research 
 
The public health burden of chronic pain is undeniable. Not only is pain related to a breadth 
of disease and injury, but chronic pain can also be the disease, itself. Chronic pain is pervasive. 
According to the Institute of Medicine of The National Academies at least 100 million Americans 
suffer from some chronic pain syndrome—a number that trumps the sum of patients suffering from 
heart disease, diabetes, and cancer combined (American Cancer Society, 2014; Institute of 
Medicine of the National Academies, 2011; Roger et al., 2011; Yang et al., 2013). The prevalence 
of chronic pain compromises the efficiency of an already overtaxed healthcare system. According 
to a 2003 nationwide survey, 63 percent of pain sufferers have visited their family physician for 
their condition, 40 percent sought out further medical care with a specialist, and at least 15 percent 
visited a physician who specializes in pain management, in particular. (Hart, 2003) 
Over the last two decades, many imaging tools have emerged that are gradually providing 
qualitative and quantitative insight into brain activation in response to noxious stimuli, as well as 
an understanding of the underlying cause of chronic pain.  Both positron emission tomography 
(PET) and blood oxygen level-dependent functional MRI (BOLD-fMRI) have played major roles 
in increasing our knowledge of neuronal and vascular processes that are taking place in the brain 
and their correlation with the sensation and perception of pain.  In particular the results of these 
studies have pointed to the existence of a pain matrix (i.e. bilateral thalamus, insula, anterior 
cingulate, SII somatosensory cortex and other supra-spinal structures) (Denk, McMahon, & 
Tracey, 2014).  The goal of many contemporary pain treatments is to influence and interact with 
the operation of this matrix. Most importantly, it is hypothesized that the malfunctioning of this 
matrix is the main culprit in many chronic pain states such as phantom limb syndrome and 
fibromyalgia. It has been postulated that appropriate modification and manipulation of this matrix 
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by chemical, electrical, biofeedback, and/or mindfulness meditation may provide new approaches 
for treatment of the many presently untreatable chronic pain cases. Activations of these areas are 
directly correlated to the intensity of an external noxious stimuli as well as pain perception, which 
result in the encoding of pain intensity felt/perceived by the individual. (Casey, Minoshima, 
Morrow, & Koeppe, 1996; Disbrow, Buonocore, Antognini, Carstens, & Rowley, 1998; Tracey et 
al., 2000)  
At present the gold standard for quantitative assessment of pain relies on self-reporting 
questionnaires. Since pain is a very subjective, private and an affective matter, therefore, self-
reporting is subjective, mood dependent and not reliable – particularly in cases of children and 
demented subjects deemed unreliable. Thus, the development of reliable tools for objective 
assessment of pain has been of great interest. In addition to self-reporting, in a typical pain clinical 
setting, physiological parameters (such as heart rate, blood pressure, respiratory, galvanic skin 
response and cutaneous blood flow) and behavioral measures (such as facial grimacing and 
guarding the painful area) have been utilized for diagnostic purposes. However, based on clinical 
experiences, these measures are found to be both unreliable and non-specific. (Ranger & Gélinas, 
2014) 
Initially positron emission tomography (PET) was used to image the activated areas of 
brain in response to noxious thermal stimuli (Borsook, Sava, & Becerra, 2010). These studies 
provided some of the earliest evidence for the present day understanding of the brain activation in 
response to painful stimuli. However, a major problem with PET is its reliance on radioactive 
contrast agent. The recent and continuous advances in functional magnetic resonance imaging 
(fMRI) have made this technique the primary brain imaging modality. Using these two modalities, 
a correlation between activated brain areas and application of noxious stimuli has been established. 
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Further, a relation between the BOLD signal acquired by fMRI and subjects’ self-report has also 
been identified. (Porro, Cettolo, Francescato, & Baraldi, 1998)  
An area that recently has had a major impact in neuroscience in general and in 
neuroimaging has been the deployment of machine-learning techniques for analyzing 
neuroimaging data. Marquand et.al. used machine-learning algorithms, namely the Gaussian 
process (GP) models, multivariate regression and probabilistic classification, to analyze the fMRI 
data obtained from the whole brain. In their study, they show that GP models can predict subjective 
pain ratings on the same individual. They favorably compared their results with the state of the art 
support vector machine (SVM) algorithm. (Marquand et al., 2010) 
In another fMRI study whole-brain activity patterns have been used to train a support 
vector machine (SVM) to distinguish painful from non-painful thermal stimulation (Brown, 
Chatterjee, Younger, & Mackey, 2011). The generated model in this study is not limited to the 
individual itself and has been verified on different groups of subjects. They have reported an 
accuracy of 81% at distinguishing painful from non-painful stimuli.  
In yet another fMRI study, machine-learning–based regression technique LASSO-PCR 
(least absolute shrinkage and selection operator-regularized principal components regression) was 
able to separate hot from mild thermal stimuli with an accuracy of 94% accuracy (Wager et al., 
2013; Wager, Atlas, Leotti, & Rilling, 2011). These studies demonstrate that neuroimaging 
biomarkers are consistent enough between subjects to create an algorithm that performs with high 
accuracy when trained on a particular group of subjects, with another separate group serving as 
the testing group (Brodersen et al., 2012). While both PET and fMRI are very powerful imaging 
modalities with great depth of penetration and spatial resolution, both modalities are expensive 
and are not designed for frequent clinical use. Later in this section in the discussion of near infrared 
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spectroscopy (NIRS) we will see that some of the same similar features can also be measured with 
NIRS, which can be effectively used in a community clinical setting. (Borsook et al., 2010) 
Complementary to the above imaging techniques that focus on blood flow, 
electroencephalography (EEG) and magnetoencephalography (MEG) provide information 
regarding real-time neuronal activity. In addition, EEG is relatively inexpensive and has a long 
history of being used in clinical settings.  Still, EEG is very sensitive to electrical noise and motion 
artifact and typically needs a shielded room. Recently, great improvements have been made in 
addressing some of the challenges associated with EEG.  As for MEG, it is fairly expensive, as it 
requires a room with magnetic shielding. (Chizh & Hobson, 2007) 
Non-invasive optical modalities such as infrared thermography and laser-doppler imaging 
provide “real time” changes in blood flow, and can assess nociceptor activation and provide 
pharmacokinetic information (Chizh & Hobson, 2007). A major shortcoming of both techniques 
is that they can only provide signals emanating from superficial tissue layers.  Each of these 
techniques and their separate focus provide great insight into the pain matrix.  Researches utilizing 
these modalities have increased our basic understanding of the pain matrix and the underlying 
causes of various chronic pain states.    
Another useful technique for neuroimaging of pain is near infrared spectroscopy (NIRS) 
(Barati et al., 2013; Chance et al., 1998; Villringer & Chance, 1997).  NIRS is a non-invasive and 
easy-to-use modality, and with the exception of its moderate depth of penetration and spatial 
resolution, it provides information similar to that of fMRI. In particular NIRS has been 
successfully used to monitor brain response to noxious stimuli (Barati et al., 2013; Chance et al., 
1998; Villringer & Chance, 1997).  NIRS is as an optical brain imaging modality that implements 
near infrared light to track changes in cerebral hemodynamic responses. Commercially available 
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NIRS system can probe 2-3 centimeters into the tissue, utilizing wavelengths within the 600 to 
900nm, known as the “optical light window.” At approximately 700nm, deoxy-hemoglobin is 
absorbed at a maximum and at approximately 900nm, oxy-hemoglobin is absorbed at a maximum 
(Barati et al., 2013).  Through modified Beer-Lambert law calculations, we obtain the changes in 
oxy and deoxy-hemoglobin concentration and an estimate of cerebral blood flow. 
In our laboratory, near infrared spectroscopy (NIRS) was successfully used as a monitor 
for the hemodynamics response to cold stimuli. In these studies, subjects immersed their right hand 
in a bucket of ice water and the autonomic responses were monitored from the forehead by a NIRS 
probe (Barati et al., 2013). The correlation between hemodynamic response measured by fNIRS 
and cold noxious stimuli has been demonstrated through several cold pressor test (CPT) studies. 
(Barati et al., 2013) 
Presently, we are improving this method by machine-learning techniques such as logistic 
regression and support-vector machine to classify the measured results taken during painful versus 
non-painful states as reported by the subject. We have found features in the signal that correlate to 
the intensity of the stimuli and were used to train a machine learning system to classify signals 
based on two levels of pains – low pain and high pain – with an accuracy of about 90%.  
Furthermore, we are planning to use other noxious stimuli that would evoke less generalized 
systemic responses such as pressure algometry and electrical stimulation in order to tease out the 
cortical response from the systemic autonomic response.  
Reliable biomarkers are of great need and importance in evidence-based, personalized 
management of pain. fNIRS has been used as a method to objectively measure the autonomic 
response to noxious stimuli and has proven to be linked to subjective pain responses (Barati et al., 
2013).  Given this information, it has been suggested that fNIRS can be used as a potential 
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technique for identifying robust biomarkers for pain and individual responses to noxious 
stimuli.  These biomarkers are essential in evidence-based pain management, as they account for 
the subjective nature of pain. (Barati et al., 2013)  
Innovation 
The diffuse optical imaging modality of functional near infrared spectroscopy (fNIRS) has 
been used for countless applications, both in the clinical setting and experimental setting, as a 
monitor of changes in body hemodynamics.  These applications demonstrate the versatility of 
fNIRS and its usefulness as an imaging modality as compared to its more expensive lacking, 
although somewhat effective, counterparts such as PET, SPECT, fMRI and EEG.  PET and SPECT 
are very similar in their use of gamma rays for 3-dimensional modeling to give high spatial 
resolution brain images (Borsook et al., 2010).  While pain, as well as adaptation to pain, are things 
have been extensively researched in the pain community, studying adaptation to pain through the 
use of this innovative diffuse optical imaging modality of fNIRS has not.  Not only this, but then 
comparing these fNIRS signals to subjective pain scores in the scope of adaptation has also yet to 
be thoroughly researched.  The research conducted in fulfillment of this dissertation will help to 
fill this gap in research and highlight the use of fNIRS in adaptation studies.  In understanding 
adaptation, what this yields is a greater understanding of the bodies’ response to pain.  For instance, 
if one never adapts to pain when undergoing pain testing, something is wrong with the way they 
adapt to pain.  What this exposes is a problem in the pain pathway, identifying a need for 
intervention preemptively as opposed to post-injury interventional treatments.  All of the previous 
work done in understanding pain, neuroimaging of pain, and pain perception, have all advanced 
pain research in a great way.  What the work here will do is help demonstrate how adaptation also 
plays a key role in understanding pain, and how it may assist clinicians in diagnosing and treating 
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pain problems in the future. EEG acts as a source localization technique through which we utilize 
electrical signals in the brain and source localization to get information about brain activity.  
Lastly, fMRI, which is most similar to fNIRS, uses BOLD imaging or blood-oxygenation-level-
dependent contrast imaging, but is far more costly when compared to fNIRS.  As the technology 
has improved and been commercialized over the last 20 years since the inception of fNIRS (Boas, 
Elwell, Ferrari, & Taga, 2014), there has been increasing interest in using this technology for 
neuroimaging research (Boas et al., 2014).  It has been used as a part of multiple applications, from 
depth of anesthesia during surgery, to assessing cognitive performance levels (Borsook et al., 
2010). Using fNIRS, its applicable reach can be anticipated to extend further by being able to 
measure multiple pain types, by monitoring the hemodynamics in the dorsolateral prefrontal cortex 
region.   
 
1.6 Outline 
 
The subsequent chapters of this thesis are organized as follows: 
Chapter 2 of this dissertation will focus on AIM 1 which focuses on the hemodynamic 
response to repeated exposure of stimuli.  This will give a view of how the response changes over 
time, and the sensitivity of the fNIRS signal to observe adaptation in healthy subjects. 
Chapter 3 will focus on the correlation of the fNIRS signals to standard perception 
measures utilized in the field of pain research.  With pain being heavily subjective in nature, it is 
important that the signal matches subjects’ subjective experience to pain.  This will be 
accomplished primarily through using three subjective measures: (1) the visual analogue scale 
(VAS), (2) the Short-Form McGill Pain Questionnaire (SF-MPQ) and (3) the state trait anxiety 
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inventory (STAI).  Looking at how the measures of perception change over time in correlation to 
the fNIRS signal will confirm findings in Chapter 2. 
Chapter 4 will focus on the use of unsupervised machine-learning techniques in an 
exploratory analysis to see if the data can be grouped into categories solely based on the signal 
response given at different time points of the repeated exposure to stimuli.  As adaptation is a 
diminished response to repeated exposure of a given stimuli, being able to separate the data into 
different groups based on time of exposure (i.e. initial exposure, final exposure) will further expand 
and confirm results obtained in Chapter 2 and Chapter 3.  It will show the clusters that could be 
defined based on trial number of repeated measure experimentation. 
Lastly, Chapter 5 will summarize the findings of the work done as a part of this dissertation, 
and suggest future work to be done in this regard. 
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Chapter 2 
 
AIM 1. fNIRS and Adaptation. Explore the adaptation of healthy subjects to repeated exposure 
of noxious stimuli. 
2.1 Introduction 
 
As a part of the peripheral nervous system, there is the autonomic nervous system that for 
the most part, unconsciously controls our bodies regulatory functions (Barati et al., 2013; Ohsawa, 
Okada, Nishijo, & Sato, 1995).  Within the autonomic nervous system there is the sympathetic 
nervous system which is responsible for our bodies physiological reaction to an event that is 
perceived as threatening or harmful in any way, also termed the “fight-or-flight” response. In 
experimental use of fNIRS, the unique feature that is taken advantage of is the “fight-or-flight” 
response.  What this does is tell the body that there is some external stimulus that is being 
experienced by the body.  In the “fight-or-flight” response, as the name indicates, the decision that 
is plaguing the brain at that moment is to fight the arousal away or flee from the location of the 
stimulus.  While the brain typically experiences pain in a multitude of areas that all contribute to 
the pain experience (i.e. the pain matrix), this unique feature of the autonomic nervous system 
allows for the use of fNIRS on the forehead to take measurements that relate to a painful 
experience. 
In this investigation, as we are focusing on adaptation, we see how the autonomic response 
is changed through exposure to thermal stimuli over time, specifically through using the cold 
pressor test (CPT).  Previous studies with fNIRS and pain have been able to prove fNIRS as a way 
to objectively detect pain (Barati et al., 2013). In these studies, the objective was simply to 
understand whether fNIRS is reliable in quantifying relative pain experienced by subjects.  Our 
study expands upon this and looks to employ a repeated measures approach to monitor the pain 
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response over time.  Thus, the goal of the experiments conducted in the scope of this chapter are 
to see how reliable the hemodynamic biomarkers obtained by the fNIRS signal can assess a 
subjects’ adaptation to repeated exposure to a stimulus over time.   
 
2.2 Materials and Methods 
 
2.2.1 fNIRS Principles and Instrumentation 
 
fNIRS Imaging and Signal Processing 
 
The fNIRS continuous-wave imaging system penetrates tissue up to 2-3cm within the 700 
to 900nm optical light window depending upon the geometrical configuration of the distance 
between detector and LED light source (see Fig. 1) (Ferrari & Quaresima, 2012). The configuration 
followed in this study was done based on several preceding studies that included theoretical and 
experimental analysis of source-detector separation (Barati et al., 2013; Ferrari & Quaresima, 
2012). 
 
Figure 1. Schematic of probe configuration. 
 
The fNIRS system can penetrate tissue up to a few centimeters within the 700 to 900nm 
optical light window.  In this window, water is minimally absorbed to allow for maximum 
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absorption of other chromophores, primarily hemoglobin in the given light window (Barati et al., 
2013). When light is emitted from the LED light source in the forehead region (see Figure 1), it is 
both scattered and absorbed. The detectors then detect the amount of light that reaches back to the 
surface of the skin due to multiple sequential scattering (Simonson & Piantadosi, 1996). The 
signals obtained from the detectors can be thought of as light intensity values as they are taking a 
measure of light scattered and light absorbed (Barati et al., 2013). Based on the changes of the 
amount of light absorbed as changed from baseline, through the modified beer-lambert law  (see 
Equation in section 2.3.4 below), a ratio is obtained that gives the changes in oxy-hemoglobin 
(HBO2) and deoxy-hemoglobin (HB) in the forehead region. The specifications behind the 
instrumentation, safety and signal to noise estimations have been studied extensively prior to 
commercial use of fNIRS modality in pain research (Barati et al., 2013).  
Constant Temperature Bath 
The CPT was used as a means of inducing acute pain from a thermal stimulus. A constant 
temperature bath (Lauda-Brinkmann RM6-RMS Refrigerating Circulating Bath) was used to 
maintain a temperature of 4°C throughout testing. This temperature has been used frequently in 
the literature as it induces pain, but not at an unbearable level – allowing subjects to endure for the 
duration of testing. (Barati et al., 2013) 
2.2.2 Subjects 
 
Healthy subjects (n=15) with no history of neurological, psychiatric or psychological 
disorders and who were not currently on any medications were recruited from the Drexel 
University community. Using the Edinburgh Handedness Inventory, subjects were confirmed to 
be right handed before study participation was allowed.  Upon understanding all experimental 
procedures, subjects were required to sign the informed consent document before participating in 
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any further study related activities. The Drexel IRB, through the university’s Human Research 
Protection Program, approved all study proceedings.  The basis for these hypotheses are found by 
precedent in previously published literature by our lab (Barati et al., 2013; Pourshoghi et. al 2015). 
2.2.3 Protocol 
 
Subjects were seated comfortably with minimal distractions for the duration of 
experimentation. All data recording was done in a dim environment to prevent the effect of ambient 
light on data recording. Subjects each had two probes on their forehead, each of which had 3 
detectors.  Channels 1, 2 and 3 were on the right-side probe and channels 4, 5 and 6 were on the 
left-side probe.  These were used to monitor the subjects’ hemodynamic response during 
experimentation.  Each experiment consisted of 7 trials of the experimental procedure post the 30-
second baseline recording.  The procedure included placing the right hand in tepid water 
(maintained at 23°C) for 2 minutes, followed by immersion of the hand in 4°C water for 30 
seconds.  After 7 trials, the subject then placed their hand in tepid water for 2 minutes to conclude 
the experiment. All subjects maintained appropriate timing by following given auditory commands 
from the experimenter. (Barati et al., 2013) This is seen in Figure 2. 
 
Figure 2. Repeated measures protocol diagram. 
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2.2.4 fNIR Data Processing 
 
Equation 1. Modified Beer-Lambert Law 
 
 
 
ΔODλ is termed the optical density. Ib is the light intensity during baseline and It is the 
baseline after a given task has been performed. ελHb and ελHbO2 are the absorption coefficients for 
the hemoglobin molecules at wavelength lambda. ΔcHb and ΔcHbO2 represent concentration 
changes in the hemoglobin molecules due to the given task.  ‘d’ represents the distance between 
the light source and photodetector.  DPFλ is the differential pathlength factor adjusted for the 
increased pathlength from source to detector due to scattering at the wavelength lambda.  When 
measured at two different wavelengths, this equation can then be solved for the change in the 
concentration of HB and HBO2 molecules. 
 
Data Collection 
 
The far detectors (distance of 2.8cm from the light source) were used in analysis post-
experimentation.  This is a common experimental practice in the use of fNIRS as the near detector 
(1cm from light source) only obtains information from the superficial layers while the far detector 
penetrates into the cortical tissue, giving information on the brain’s response to stimulation. 
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Figure 3. Example near infrared spectroscopy signal of oxy and deoxyhemoglobin. 
Preprocessing of Data 
Data was collected at a sampling frequency of 2Hz and analyzed through the use of 
MATLAB (R2015a, MathWorks, Natwick, MA). Smoothing techniques were performed through 
using the functional data analysis (fDA) package in MATLAB, coupled with a finite impulse 
response low-pass filter with a cutoff frequency of 0.14Hz as determined based on previous fNIRS 
studies (Barati et al., 2013). This helped to reduce noise and motion artifact, as well as heart rate 
and respiration influence on the signals (Barati et al., 2013). HbO2 and HHb concentrations were 
calculated in comparison to their baseline optical intensity values that were obtained in the pre-
stimulus period, which consists of a 30-second baseline period.  Bspline basis expansion is used 
to impose a penalty on roughness of the second derivative of the data with lambda values of 300; 
the total hemoglobin is calculated in addition to the concentrations of oxy and deoxy-hemoglobin 
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were calculated in relation to their baseline optical intensity values obtained in the pre-stimulus 
30-second baseline period. See Figure 3 for an example of what this processing produces. 
Statistical Analysis 
With univariate repeated measures ANOVA, time is considered as a categorical variable 
(Tak & Ye, 2014). This allows for comparisons of one time point to another (e.g. comparing trial 
1 to trial 3, trial 1 to trial 3, etc.).  Therefore, multilevel modeling (MLM) growth or decay models 
proved useful in this analysis, as time is considered a continuous variable.  This allows for 
observations of changes over time (e.g. slope from trial 1 through trial 7, the significance of the 
slope, etc.).   It also accounts for any unequal spacing between time intervals and unbalanced data, 
and can increase the statistical power of detecting growth or decay effects. (Kwok et al., 2008)  
Another considered approach is linear regression; however, compared to this mixed model 
approach, regression requires that observations are independent of one another.  Here, we have 
repeated measures and thus, this assumption is violated so we cannot use regular regression.  With 
multilevel modeling being hierarchical in nature, it allows for random intercepts and slopes for 
different subjects (Kwok et al., 2008). These rationales highlight why multilevel modeling was 
used in the case of the repeated measures cold pressor test employed in this chapter.  A summary 
of results can be found in tables 1 through 4, with graphical representations of the results of each 
channel displayed in Figures 4 through 27.  Significance of change is identified in this chapter by 
the following designations: *=Significance of p< 0.10, **= Significance of p <0.05, and 
***=Significance of p < 0.01. 
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2.3 Results 
 
2.3.1 Multilevel Modeling of Deoxyhemoglobin for Trial 1 through Trial 7 
 
 In using multilevel modeling for deoxyhemoglobin, the best model used for channels 1 
through 6 allowed the intercept to vary across subjects.  When looking at deoxyhemoglobin for 
channel 1, a near channel, what we see is that over time (trials 1 through 7), we see that 4°C 
starts with a ΔHB of 0.062 at trial 1, with a negative slope of -0.024 over time to trial 7.  The 
results are shown in Figure 4; there was no significant change to ΔHB over time.  In 15°C we see 
similar results with a starting point of -0.145 for change in deoxyhemoglobin and a small slope 
of -0.001.  Also, show in in Figure 4, the results for 15°C do not show a significant change in 
ΔHB over time. 
 
Figure 4. Channel 1 (near channel – 1cm) comparison of the change in deoxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. Black dots represent the average of all 
subjects’ ΔHB at each trial for 4 degrees Celsius. 
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For channel 2, we see that 4°C starts with a ΔHB of -0.391 at the first trial and a positive 
slope of 0.037 over time through to trial 7.  These results are shown in Figure 5 with no 
significant change in ΔHB over time.  Similarly, for 15°C, the grand mean at trial 1 is -0.119 and 
a negative slope of -0.008 as it moves through to trial 7.  These results are also shown in Figure 5 
and demonstrate no significance in the ΔHB over time. 
 
Figure 5. Channel 2 (far channel – 2.8cm) comparison of the change in deoxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius.  Black dots represent the average of all 
subjects’ ΔHB at each trial for 4 degrees Celsius. 
 
 When looking at the results for channel 3, 4°C shows a ΔHB of -0.362 during the initial 
exposure with a slope of 0.047; these results were significant with a p-value of 0.044.  This 
shows that the change in deoxyhemoglobin significantly changed over time in the case of 
channel 3 at 4°C; whereas, in the case of 15°C, with a starting point of 0.001 for change ΔHB, 
and a small negative slope of -0.012, there was no significant change in ΔHB over time from trial 
1 through trial 7.  These results are shown in Figure 6. 
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Figure 6. Channel 3 (far channel – 2.8cm) comparison of the change in deoxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius.  Black dots represent the average of all 
subjects’ ΔHB at each trial for 4 degrees Celsius. 
 
 ΔHB for channel 4 at 4°C shows a trial 1 grand mean of -0.222 with a slope of 0.075, that 
showed a significant increase over time with a p-value of 0.039 when looking at the change over 
time from trial 1 through trial 7.  When comparing this to 15°C, as demonstrated in Figure 7, 
there was, in contrast, no significant change over time, with a trial 1 grand mean of -0.150 and a 
minimal slope of 0.006. 
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Figure 7. Channel 4 (near channel – 1cm) comparison of the change in deoxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius.  Black dots represent the average of all 
subjects’ ΔHB at each trial for 4 degrees Celsius. 
 
For channels 5 and 6 at 4°C, the trial 1 grand means for ΔHB were -0.418 and -0.356 
respectively with matching slopes of 0.077 and 0.067.  Both positive slopes showed a significant 
change over time from trials 1 through trial 7 (4°C at channel 5 p-value: 0.003; 4°C channel 6 p-
value: 0.003).  Lastly, for ΔHB at 15°C, the grand means for trial 1 of -0.115 and 0.009 and 
slopes of 0.003 and -0.009 respectively did not show any significant change over time (15°C at 
channel 5 p-value: 0.897; 15°C channel 6 p-value: 0.763).  These results are shown in Figure 8 
and Figure 9. 
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Figure 8. Channel 5 (far channel – 2.8cm) comparison of the change in deoxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius.  Black dots represent the average of all 
subjects’ ΔHB at each trial for 4 degrees Celsius. 
 
Figure 9. Channel 6 (far channel – 2.8cm) comparison of the change in deoxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius.  Black dots represent the average of all 
subjects’ ΔHB at each trial for 4 degrees Celsius. 
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Channels Temperature Trial 1 (grand 
mean) 
Slope p-Value 
 
1 (1cm) 
4˚C 0.062 -0.024 0.846 
15˚C -0.145 -0.001 0.984 
 
2 (2.8cm) 
4˚C -0.391 0.037 0.258 
15˚C -0.119 -0.008 0.591 
 
3 (2.8cm) 
4˚C -0.362 0.047 0.044** 
15˚C 0.001 -0.012 0.461 
 
4 (1cm) 
4˚C -0.222 0.075 0.039** 
15˚C -0.150 0.006 0.833 
 
5 (2.8cm) 
4˚C -0.418 0.077 0.003*** 
15˚C -0.115 0.003 0.897 
 
6 (2.8cm) 
4˚C -0.356 0.067 0.003*** 
15˚C 0.009 -0.009 0.763 
Table 1. (Deoxyhemoglobin) Numerical results from Figure 4 through Figure 9 showing the 
grand mean for trial 1, the representative slope for the model fitting, followed by the significance 
value (*=Significance of p< 0.10, **= Significance of p <0.05, and ***=Significance of p < 
0.01). 
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2.3.2 Multilevel Modeling of Deoxyhemoglobin for Trial 2 through Trial 7 
 
 Now we can move to the case of Trials 2 through 7.  In this case, as trial 1 proved to be 
the most significant in that initial exposure causes the greatest disturbance to the system.  As a 
result, we have removed trial 1 from the analysis of deoxyhemoglobin in this section and are 
solely looking at trials 2 through 7.  For all figures in this section (Figure 10 through Figure 15), 
all figures with trial numbers numbered 1 through 6 refers to the order of the trial and not the 
actual trial number (i.e. trial 1 is the first trial, so trial 2, trial 2 is the second trial, so trial 3, etc.). 
 For ΔHB in channel 1 (see Figure 10) when looking at 4°C and 15°C, the first trial (trial 
2) grand mean is -0.205 and -0.158, with slopes of 0.035 and 0.003 respectively.  The p-value for 
4°C is 0.147 and for 15°C is 0.933, showing that for ΔHB there is no significant change over 
time when removing the initial exposure from the analysis.  In this section, the average of ΔHB 
was not shown represented as dots on each graph as the results for this would be the same as in 
the previous section. 
 
Figure 10. Channel 1 (near channel – 1cm) comparison of the change in deoxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
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When considering channels 2 and 3 (both far channels on the right side), the trial 2 grand 
means for ΔHB were -0.319 and -0.182 for 4°C and -0.307 and 0.037 for 15°C.  Upon further 
analysis, there slopes were 0.027 and 0.007, and -0.014 and -0.026 respectively.  Overall, 
regardless of temperature, in channels 2 and 3, there was no significance observed over time 
from trial 2 through 6 when removing the initial exposure to the thermal stimuli.  Summaries of 
this data can be viewed in Figures 11 and 12; details of results for channels 2 and 3 can be seen 
in Table 2. 
 
Figure 11. Channel 2 (far channel – 2.8cm) comparison of the change in deoxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
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Figure 12. Channel 3 (far channel – 2.8cm) comparison of the change in deoxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
 
Details for channels 4 and 5 can be found in Table 2, and seen graphically in Figures 13 
and 14; however, they are similar to results found in channels 1, 2 and 3 in that the grand means 
in conjunction with the small slopes when modeling ΔHB, do not demonstrate a significant 
change over time (when looking solely at trials 2 through 6 after removing the initial exposure 
from analysis). 
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Figure 13. Channel 4 (near channel – 1cm) comparison of the change in deoxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
 
 
 
Figure 14. Channel 5 (far channel – 2.8cm) comparison of the change in deoxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
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Lastly, when looking at the channel 6 data for ΔHB at 4°C, the grand mean for the first 
trial (trial 2) is -0.381 with a slope of 0.094.  The resulting p-value from this is 0.004 which 
shows that there was a significant increase over time in ΔHB when looking at trials 2 through 7.  
When looking at the channel 6 data for ΔHB at 15°C, the grand mean for the first trial is -0.038 
with a slope of 0.002, yielding a p-value of 0.954; thus, there was no significant change over 
time in the case of channel 6 at 15°C.  This can be seen graphically in Figure 15. 
 
Figure 15. Channel 6 (far channel – 2.8cm) comparison of the change in deoxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
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Channels Temperature Trial 2 (grand 
mean) 
Slope p-Value 
 
1 (1cm) 
4˚C -0.205 0.035 0.147 
15˚C -0.158 0.003 0.933 
 
2 (2.8cm) 
4˚C -0.319 0.027 0.150 
15˚C -0.107 -0.014 0.428 
 
3 (2.8cm) 
4˚C -0.182 0.007 0.853 
15˚C 0.037 -0.026 0.198 
 
4 (1cm) 
4˚C -0.171 0.082 0.084 
15˚C -0.228 0.031 0.374 
 
5 (2.8cm) 
4˚C -0.094 0.002 0.909 
15˚C -0.107 0.001 0.974 
 
6 (2.8cm) 
4˚C -0.381 0.094 0.004*** 
15˚C -0.038 0.002 0.954 
Table 2. (Deoxyhemoglobin) Numerical results from Figure 10 through Figure 15 showing the 
grand mean for trial 2 (shown graphically as trial number 1 as it is overall trial number 2 but the 
first trial in this analysis), the representative slope for the model fitting, followed by the 
significance value (*=Significance of p< 0.10, **= Significance of p <0.05, and 
***=Significance of p < 0.01). 
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2.3.3 Multilevel Modeling of Oxyhemoglobin for Trial 1 through Trial 7 
 
In using multilevel modeling for oxyhemoglobin, the best model used for channels 1 
through 6 allowed the intercept to vary across subjects.  When looking at oxyhemoglobin for 
channel 1, a near channel, what we see is that over time (trials 1 through 7), we see that 4°C 
starts with a change in the ΔHBO2 of 0.038 at trial 1, with a positive slope of 0.118 over time to 
trial 7.  The results are shown in Figure 16; there was no significant change to ΔHBO2 over time.  
In 15°C we see similar results with a starting point of -0.124 for change in oxyhemoglobin and a 
small slope of 0.058.  Also, show in in Figure 16, the results for 15°C do not show a significant 
change in ΔHBO2 over time.  Further details of this are outlined in Table 3. 
 
Figure 16. Channel 1 (near channel – 1cm) comparison of the change in oxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius.  Black dots represent the average of all 
subjects’ ΔHBO2 at each trial for 4 degrees Celsius. 
 
For channel 2, we see that 4°C starts with a ΔHBO2 of 2.101 at the first trial and a 
negative slope of -0.280 over time through to trial 7.  These results are shown in Figure 17 with a 
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significant change in ΔHBO2 over time with a p-value of 0.001.  Similarly, for 15°C, the grand 
mean at trial 1 is 0.008 and a positive slope of 0.013 as it moves through to trial 7.  These results 
are also shown in Figure 17 and demonstrate no significance in the ΔHBO2 over time. 
 
 
Figure 17. Channel 2 (far channel – 2.8cm) comparison of the change in oxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius.  Black dots represent the average of all 
subjects’ ΔHBO2 at each trial for 4 degrees Celsius. 
 
 When looking at channels 3 and 4 for ΔHBO2, the only case that showed significance is 
that of channel 3 at 4°C with a trial 1 grand mean of 1.811 and a slope of -0.256 with a p-value 
of 0.004 – demonstrating a significant reduction in ΔHBO2 over time.  The remaining cases 
(channel 3 15°C, and channel 4 4°C and 15°C all did not show significant changes over time for 
ΔHBO2; results detailing this are shown in Table 3 and graphically represented in Figures 18 and 
19. 
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Figure 18. Channel 3 (far channel – 2.8cm) comparison of the change in oxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius.  Black dots represent the average of all 
subjects’ ΔHBO2 at each trial for 4 degrees Celsius. 
 
 
Figure 19. Channel 4 (near channel – 1cm) comparison of the change in oxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius.  Black dots represent the average of all 
subjects’ ΔHBO2 at each trial for 4 degrees Celsius. 
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In the case of channels 5 and 6 (both far channels monitoring hemoglobin on the left side 
of the forehead), both channels showed a significant difference.  Channel 5 at 4°C with a trial 1 
grand mean of 1.044 and a negative slope of -0.186 with a p-value of 3.080E-6, and channel 6 at 
4°C with a trial 1 grand mean of 1.137 and a negative slope of -0.243 with a p-value of 2.701E-5 
– demonstrating a significant decrease in ΔHBO2 over time.  All other cases did not show 
significant changes over time for ΔHBO2; these results can also be found in Table 3 and are 
represented visually in the graphs in Figures 20 and 21. 
 
Figure 20. Channel 5 (far channel – 2.8cm) comparison of the change in oxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius.  Black dots represent the average of all 
subjects’ ΔHBO2 at each trial for 4 degrees Celsius. 
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Figure 21. Channel 6 (far channel – 2.8cm) comparison of the change in oxyhemoglobin over 
time from trial 1 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius.  Black dots represent the average of all 
subjects’ ΔHBO2 at each trial for 4 degrees Celsius. 
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Channels Temperature Trial 1 (grand 
mean) 
Slope p-Value 
 
1 (1cm) 
4˚C 0.038 0.118 0.702 
15˚C -0.124 0.058 0.137 
 
2 (2.8cm) 
4˚C 2.101 -0.280 0.001*** 
15˚C 0.008 0.013 0.768 
 
3 (2.8cm) 
4˚C 1.811 -0.256 0.004*** 
15˚C -0.036 0.013 0.727 
 
4 (1cm) 
4˚C 0.667 -0.039 0.436 
15˚C -0.033 0.002 0.963 
 
5 (2.8cm) 
4˚C 1.044 -0.186 3.080E-6*** 
15˚C -0.078 -0.018 0.650 
 
6 (2.8cm) 
4˚C 1.137 -0.243 2.701E-5*** 
15˚C -0.016 -0.129 0.741 
Table 3. (Oxyhemoglobin) Numerical results from Figure 16 through Figure 21 showing the 
grand mean for trial 2, the representative slope for the model fitting, followed by the significance 
value (*=Significance of p< 0.10, **= Significance of p <0.05, and ***=Significance of p < 
0.01). 
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2.3.4 Multilevel Modeling of Oxyhemoglobin for Trial 2 through Trial 7 
 
Lastly, as was done in section 2.4.4 of this chapter, we can move to the case of Trials 2 
through 7.  This resulted in findings similar to what was done with deoxyhemoglobin, we have 
removed trial 1 from the analysis of oxyhemoglobin in this section and are solely looking at trials 
2 through 7.  For all figures in this section (Figure 22 through Figure 27), all figures with trial 
numbers numbered 1 through 6 refers to the order of the trial and not the actual trial number (i.e. 
trial 1 is the first trial, so trial 2, trial 2 is the second trial, so trial 3, etc.). 
 For all cases in ΔHBO2 when looking at trials 2 through 6 for channels 1 through 6, 
regardless of channel or temperature, there was no significance demonstrated in terms of the 
changes in ΔHBO2 over time when the initial exposure to the thermal stimuli was removed from 
analysis.  These results can be seen in Figures 22 through 27 and are detailed in Table 4.  In this 
section, the average of ΔHBO2 was not shown represented as dots on each graph as the results 
for this would be the same as in the previous section. 
 
Figure 22. Channel 1 (near channel – 1cm) comparison of the change in oxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
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Figure 23. Channel 2 (far channel – 2.8cm) comparison of the change in oxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
 
 
Figure 24. Channel 3 (far channel – 2.8cm) comparison of the change in oxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
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Figure 25. Channel 4 (near channel – 1cm) comparison of the change in oxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
 
 
Figure 26. Channel 5 (far channel – 2.8cm) comparison of the change in oxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
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Figure 27. Channel 6 (far channel – 2.8cm) comparison of the change in oxyhemoglobin over 
time from trial 2 through trial 7 using multilevel modeling to estimate a slope for rate of change 
for both 4 degrees Celsius and 15 degrees Celsius. On the x-axis, trial number is representative 
of the trial order and not of the trials used in analysis. 
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Channels Temperature Trial 2 (grand 
mean) 
Slope p-Value 
 
1 (1cm) 
4˚C 0.725 -0.053 0.223 
15˚C -0.151 0.838 0.075 
 
2 (2.8cm) 
4˚C 0.945 -0.017 0.704 
15˚C -0.071 0.040 0.456 
 
3 (2.8cm) 
4˚C 0.908 -0.062 0.245 
15˚C -0.054 0.022 0.641 
 
4 (1cm) 
4˚C 0.625 -0.038 0.346 
15˚C -0.151 0.038 0.540 
 
5 (2.8cm) 
4˚C 0.443 -0.062 0.106 
15˚C -0.191 0.010 0.838 
 
6 (2.8cm) 
4˚C 0.336 -0.021 0.636 
15˚C -0.362 0.049 0.441 
Table 4. (Oxyhemoglobin) Numerical results from Figure 22 through Figure 27 showing the 
grand mean for trial 2 (shown graphically as trial number 1 as it is overall trial number 2 but the 
first trial in this analysis), the representative slope for the model fitting, followed by the 
significance value (*=Significance of p< 0.10, **= Significance of p <0.05, and 
***=Significance of p < 0.01). 
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2.4 Discussion 
 
In performing the analysis on the data over trials 1 through 7, we met the original goal of 
this investigation which was simply to observe adaptation with functional near infrared 
spectroscopy.  We see that multilevel modeling provided a great perspective on how the 
hemodynamic response to experimental pain changed over time using fNIRS.  While the near 
channels (channel 1 and 4 detectors at approximately 1cm from the light source) do not show 
consistency, as was expected when observing superficial tissue layers, the far channels overall 
show a consistent reduction in the change in hemodynamic response, the more times a subject is 
exposed to the thermal external stimuli.  More specifically, we see that channel 5 consistently 
showed great significance when looking at change over time.  This reduction in the change of 
response follows the definition of adaptation, however, in the context of the fNIRS signal.  The 
reason behind these findings in the far channels (detectors at 2.8cm away from the light source) is 
because with detectors at this distance, the light penetrates to a depth that reaches cortical tissues.  
At this depth, the hemodynamics monitored in this region are more related to activity that results 
from the autonomic response generated by stimuli.  Given these results, we achieved the first 
hypothesis outlined in AIM 1 in that adaptation showed through a diminished response in the signal 
over time.  Although not all cases were significant, what the results suggest are further 
investigation into adaptation (i.e. more trials during experimentation). 
Upon removing trial 1 from the analysis and only looking at trial 2 through 6, we see that 
trial 1 is heavily influential when looking at rate of change over time.  The rationale behind the 
removal of trial 1 is due to several other factors that influence the initial exposure to a stimulus, 
which can be considered the novelty of the initial exposure to experimental pain.  In subsequent 
trials, this factor is removed and primarily where adaptation takes place; however, without the 
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initial exposure, there would be no stimulus to adapt to.  This is seen in the data because when 
excluding trial 1 from analysis, the change over time was minimal regarding both Oxy and 
Deoxyhemoglobin.  What this suggests is that the initial exposure to a stimulus initiates a response 
that causes a great change in the hemodynamics monitored in the prefrontal cortex region. (Barati 
et al., 2013)  As there is no significance seen when only looking at trials 2 through 6, this suggests 
that from the initial exposure to the first repeated exposure (second trial), the greatest amount of 
adaptation occurs; however, further investigation would need to be done to confirm these findings.  
Following this, while a level of adaptation may still occur, it is minimal as there is no longer a 
great disturbance to the system, creating a situation where the body finds no need to adapt – fine 
tuning its response to re-achieve a level of stability.   
What this may represent is the bodies’ ability to adapt to external stimuli to the system, in 
an effort to not remain in a heightened state of “fight or flight”, which would give its own set of 
problems as the body is not meant to constantly remain in such a heightened state. (Romero, 
Dickens, & Cyr, 2009)  In general, to remain healthy, the body constantly strives for a level of 
homeostasis that keeps the bodies systems in order and functioning efficiently.  The autonomic 
response often changes the bodies focus.  The area of focus is shifted to where the external stimuli 
was applied, and often until the body can react appropriately and account for the given stimuli 
(adapt), the body does not return to its healthy state. 
Further, we also learned that the rate of change between 4°C and 15°C differs significantly 
and that subjects demonstrated a greater rate of change over time to 4°C than they did to 15°C; or, 
the magnitude of the hemodynamic response decreased significantly over time when looking at 
4°C and did not greatly change when looking at 15°C.  This met the criteria of the second 
hypothesis established in AIM 1 in that adaptation would look different at the two temperatures.  
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In addition, this further supports the findings from removing trial 1 from analysis – without an 
initial stimulus that causes a great change in hemodynamic response, minimal to no adaptation is 
observed as there is nothing to adapt to. 
 
2.5 Conclusion 
 
 In conclusion, the goal of this investigation was met as we observed adaptation through 
measurements from the fNIRS signal, by monitoring the effect of repeated exposure to 
experimental pain on hemodynamics in the prefrontal cortex region.  The hemodynamic response 
to repeated exposure of noxious stimuli (4°C) shows a diminished response over time when 
monitored by fNIRS.  Innocuous stimuli (15°C) did not show significant adaptation, which can 
be explained in that the initial exposure did not cause a great change to the system, and thus, did 
not warran adaptation.  Upon further study, this information about adaptation and the way 
subjects respond to repeated exposure, can show clinicians the state of an individuals’ pain 
pathways, allowing them to apply treatment sooner rather than later, and in a more targeted way. 
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Chapter 3 
 
SPECIFIC AIM 2. Perception of Pain and Adaptation.  In this aim, we want to see if there is 
a correlation between the perceived adaptation to pain and the fNIRS signal.   
3.1 Introduction 
 
The perception of pain is a complicated phenomenon as it combines dynamic interplay 
between the peripheral and central nervous system.  Due to the unpleasantness of pain, it is 
something that is avoided, yet necessary, which adds to its’ complexity.  Its necessity stems from 
the awareness it gives of any external danger in the environment that may be harmful to the body.  
Even further, acute pain is adaptive and results in survival actions being taken such as escaping 
behaviors.  In contrast, chronic pain is maladaptive causing suffering and a great reduction in life 
expectancy.  The issue with pain in general is that the human pain conditions present in a multitude 
of biological and psychological phenotypes, in particular, idiopathic pain disorders.  
Environmental events that invoke tissue injury and psychological distress also add to the difficulty 
for diagnosis due to the way that they can influence amplification of pain.  Realizing the 
importance of this as well as understanding that pain is a personal experience where generalizations 
are not always applicable, this investigation proposes the pairing of subjective pain measures with 
the objective hemodynamic response to pain in an effort to see the correlation between these two. 
While these past studies have compared fNIRS signals to subjects’ pain reporting using the 
visual analog scale (VAS) or the numerical pain rating scale (NRS-11), further analysis beyond 
this is necessary to continue to improve the utility of fNIRS in quantifying pain.  This will be done 
by assessing the sensitivity of fNIRS in quantifying pain experiences as they relate to the 
individual. (Barati et al., 2013) 
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In the first aim, we saw that when looking at ΔHBO2 and ΔHB, we observed a diminished 
response after repeated exposure to noxious stimuli (adaptation over time).  The next step to answer 
the question of how the perception of adaptation compares to the hemodynamic response of 
adaptation observed through fNIRS.  As a result, in AIM 2 we intend to expand on the previous 
fNIRS studies relating to adaptation, by including more psychological measures such as the McGill 
Pain Questionnaire and the State Trait Anxiety Inventory.  From this, we want to look at how the 
fNIRS signal looks when compared to a subjects’ perception.  Pain scores (pain level from 0-10) 
have proven to be a good tool in predicting a subjects’ response to pain.  With this, we will perform 
correlation analyses to see how strongly (or weakly) correlated the measures of perception are 
when looking at the adaptation trend in the fNIRS data. 
3.2 Materials and Methods 
 
Experimental Approach (n=16): Two subjective questionnaire were used as a means to 
asses each individuals pain experience, the State Trait Anxiety Inventory (STAI) and the Short-
Form McGill Pain Questionnaire (SF-MPQ). The STAI gives a measure of two anxiety constructs, 
state and trait, the former being a measure of the tendency to anxiously in response to a stimulus 
that is perceived as threatening and the latter being a measure of arousal in response to a stimuli 
that is seen as dangerous (R Melzack, 1987). This inventory was given before data collection began 
and after it was complete. This would assist in distinguishing a subjects’ feeling of anxiety upon 
entering the study, and anxiety that was caused by the study. As pain and anxiety are linked through 
the stress that is accompanied through painful stimulation experiences, this measure proved to be 
useful during analysis. (R Melzack, 2001) 
The MPQ has become a standard questionnaire used to quantify the subjective pain 
experience (R Melzack, 1987). As this questionnaire is 40 questions in length, for timing purposes 
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during experimentation, the SF-MPQ was used. Both forms serve the same purpose in that they 
measure subjective pain through analyzing sensory and affective pain descriptors, the former 
focusing on the emotional and feeling response to pain and the latter focusing on the quality, 
intensity and location of pain. This questionnaire was asked after the first-hand immersion in the 
4°C water bath, after the mid-point hand immersion in the 4°C water bath and lastly after the final 
hand immersion in the 4°C water bath. This tool will give information as to whether the pain 
experienced by the individual changes throughout the experiment. 
Following the experimental model used in Barati et al., two fNIRS probes of the same 
configuration were secured on each subjects’ forehead at a position proximal to the anterior median 
line. 
After each CPT when subjects were asked to place their hand in tepid water, in addition to 
the questionnaires that were asked at the time described above, subjects were asked to rate their 
pain on a numerical scale of 0 to 10 (NIRS-11).  The scale defining ‘0’ as no pain and ‘10’ being 
the worst pain imaginable. (R Melzack, 1987; Sjolund & Persson, 2007) 
Statistical Analysis 
 To compare the fNIRS data with the subjective pain measures, the approach used here is 
that of simple linear regression.  This type of regression calculates the equation that minimizes the 
distance between the fitted line and all the data points.  On each axis are the two measures that are 
to be correlated.  The linear correlation coefficient (r) looks at both the strength and direction of 
the linear relationship between the two variables of interest.  The coefficient of determination (r2) 
gives the amount of predictable variance between the two variables. (Ravn, Frederiksen, Skovsen, 
Christrup, & Werner, 2012; Tak & Ye, 2014) 
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3.2.1 Subjects 
 
Healthy subjects (n=16) with no history of neurological, psychiatric or psychological 
disorders and who were not currently on any medications were recruited from the Drexel 
University community. The Edinburgh Handedness Inventory, confirmed that subjects were  right 
handed before study participation was allowed.  When subjects clearly confirmed their 
understanding of the experimental procedures that they are voluntarily participating in, they were 
required to sign the informed consent document before participating in any further study related 
activities. The Drexel IRB, through the university’s Human Research Protection Program, 
approved all study proceedings.   
3.2.2 Protocol 
 
 
Figure 28. State trait anxiety inventory administration protocol. 
 
Figure 29. Short-Form McGill Pain Questionnaire administration protocol. 
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3.2.3 Measurements 
 
See section 2.3.1 and 2.3.4 for details on fNIRS measurements and analysis. 
 
3.3 Results 
 
3.3.1 fNIRS Signal Correlation with the Visual Analogue Scale at 4 degrees Celsius and 15 
degrees Celsius 
 
 VAS demonstrates a significant difference between pain experienced at 4°C and 15°C 
(Baseline mean VAS=0 +/- 0; 4˚C mean VAS=6.93 +/- 0.4137; 15˚C mean VAS=2.943 +/- 
1.9221). Mean displayed with SE bars (n=16).  This was identified through the use of a two-tailed 
t-test for comparison.  Baseline vs. 4˚C: p=0.003; Baseline vs. 15˚C: p=0.003; 4°C vs. 15°C: 
p=0.001.  A graphical display of these results can be found in Figure 30.    Significance of change 
is identified in this chapter by the following designations: *=Significance of p< 0.10, 
**=Significance of p <0.05, and ***=Significance of p < 0.01.  What this shows is that between 
baseline and 4°C, baseline and 15°C, and 4°C and 15°C, there was a significant difference between 
the average pain score over all trials for a given temperature (excluding baseline as this was a 
measure of pain score without any stimuli given).   
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3.3.2 fNIRS Signal Correlation (Deoxyhemoglobin) with the Visual Analogue Scale Pain 
Scores using Simple Linear Regression at 4°C 
 
The scatter plot when using channels 3, 5 and 6, which were the channels that 
demonstrated significance for ΔHB are shown in Figure 31.  Although the linear regression 
results show a slightly positive correlation (the greater the change in deoxyhemoglobin, the 
higher the pain score), the results based on the r (r=0.286) and R2 (R2 = 0.082) value show that 
there is no definitive correlation between fNIRS signal and subjects’ pain score (residual sum of 
squares = 228.269). 
The linear regression results when using only channel 5, which was the most significant 
for ΔHB, show a slightly positive correlation (the greater the change in deoxyhemoglobin, the 
higher the pain score).  The results based on the r (r=0.0.091) and R2 (R2 = 0.008) value show 
that there is no definitive correlation between fNIRS signal and subjects’ pain score (residual 
sum of squares = 246.532). 
 
Figure 31. Scatter plot with changes in deoxyhemoglobin (channels 3, 5 and 6) on the x-axis and 
pain score on the y-axis. 
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3.3.3 fNIRS Signal Correlation (Oxyhemoglobin) with the Visual Analogue Scale Pain 
Scores using Simple Linear Regression at 4°C 
 
The scatter plot when using only channels 2, 3, 5 and 6 which were the most significant 
for ΔHBO2 are shown in Figure 32.  Although the linear regression results show a slightly 
positive correlation (the greater the change in oxyhemoglobin, the higher the pain score), the 
results based on the r (r=0.374) and R2 (R2 = 0.140) value show that there is no definitive 
correlation between fNIRS signal and subjects’ pain score (residual sum of squares = 213.888). 
The linear regression results when using only channels 5, which was the most significant 
for ΔHBO2, show a slightly positive slope (the greater the change in oxyhemoglobin, the higher 
the pain score).  The results based on the r (r=0.127) and R2 (R2 = 0.016) value show that there is 
no definitive correlation between fNIRS signal and subjects’ pain score (residual sum of squares 
= 244.587). 
 
Figure 32. Scatter plot with changes in oxyhemoglobin (channels 2, 3, 5 and 6) on the x-axis and 
pain score on the y-axis. 
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3.3.4 fNIRS Signal Correlation (Deoxyhemoglobin) with the Visual Analogue Scale Pain 
Scores using Simple Linear Regression at 4°C with only Trial 1 Data 
 
From AIM 1, it was identified that trial 1 presents significantly different data from trials 2 
through 6.  As a result, there are 8 additional linear regressions that were performed here.  The 
next four will place a focus on trial 1, with the subsequent for focusing on trials 2 through 6. 
The scatter plot when using channels 3, 5 and 6, which were the channels that 
demonstrated significance for ΔHB (while only focusing on trial 1) are shown in Figure 33.  
Although the linear regression results show a slightly positive correlation, the results based on 
the r (r=0.427) and R2 (R2 = 0.182) value show that there is no definitive correlation between 
fNIRS signal and subjects’ pain score (residual sum of squares = 25.287). 
The linear regression results when using only channel 5, which was the most significant 
for ΔHB (while focusing only on trial 1) show a slightly positive correlation.  The results based 
on the r (r=0.106) and R2 (R2 = 0.011) value show that there is no definitive correlation between 
fNIRS signal and subjects’ pain score (residual sum of squares = 30.575). 
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Figure 33. Simple linear regression plot with changes in deoxyhemoglobin (channels 3, 5 and 6) 
on the x-axis and pain score on the y-axis. 
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3.3.5 fNIRS Signal Correlation (Oxyhemoglobin) with the Visual Analogue Scale Pain 
Scores using Simple Linear Regression at 4°C with only Trial 1 Data 
 
The scatter plot when using only channels 2, 3, 5 and 6 which were the most significant 
for ΔHBO2 (while focusing only on trial 1) are shown in Figure 34.  Although the linear 
regression results show a slightly positive correlation, the results based on the r (r=0.420) and R2 
(R2 = 0.176) value show that there is no definitive correlation between fNIRS signal and 
subjects’ pain score (residual sum of squares = 25.473). 
The linear regression results when using only channels 5 which was the most significant 
for ΔHBO2, show a slightly positive correlation.  The results based on the r (r=0.028) and R2 (R2 
= 0.001) value show that there is no definitive correlation between fNIRS signal and subjects’ 
pain score (residual sum of squares = 30.898). 
 
 
Figure 34. Scatter plot with changes in oxyhemoglobin (channels 2, 3, 5 and 6) on the x-axis and 
pain score on the y-axis. 
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3.3.6 fNIRS Signal Correlation (Deoxyhemoglobin) with the Visual Analogue Scale Pain 
Scores using Simple Linear Regression at 4°C after Removing Trial 1 Data 
 
Upon completing the linear regression analysis for these 4 analyses, we continued the 
investigation by repeating the same 4 analyses after removing trial 1 from the data.  As we 
observed in AIM 1, trial 1 gives a response indicative of initial exposure to a stimulus, and is not 
representative of the adaptation that follows.  To corroborate these findings, we proceeded with 
the analyses seen below. 
The scatter plot when using channels 3, 5 and 6, which were the channels that 
demonstrated significance for ΔHB (after removing trial 1 signals from the data) are shown in 
Figure 35.  Although the linear regression results show a slightly positive correlation (the greater 
the change in deoxyhemoglobin, the higher the pain score), the results based on the r (r=0.417) 
and R2 (R2 = 0.174) value show that there is no definitive correlation between fNIRS signal and 
subjects’ pain score (residual sum of squares = 179.183). 
The linear regression results when using channel 5, which was the channel that 
demonstrated significance for ΔHB (after removing trial 1 signals from the data), show a slightly 
positive correlation (the greater the change in deoxyhemoglobin, the higher the pain score).  The 
results based on the r (r=0.074) and R2 (R2 = 0.005) value show that there is no definitive 
correlation between fNIRS signal and subjects’ pain score (residual sum of squares = 215.987). 
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Figure 35. Scatter plot with changes in deoxyhemoglobin (channels 3, 5 and 6) on the x-axis and 
pain score on the y-axis. 
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3.3.7 fNIRS Signal Correlation (Oxyhemoglobin) with the Visual Analogue Scale Pain 
Scores using Simple Linear Regression at 4°C after Removing Trial 1 Data 
 
The scatter plot when using only channels 2, 3, 5 and 6 which were the most significant 
for ΔHBO2 (after removing trial 1 signals from the data) are shown in Figure 36.  Although the 
linear regression results show a slightly positive correlation (the greater the change in 
oxyhemoglobin, the higher the pain score), the results based on the r (r=0.437) and R2 (R2 = 
0.191) value show that there is no definitive correlation between fNIRS signal and subjects’ pain 
score (residual sum of squares = 175.456). 
The linear regression results when using only channels 5, which was the most significant 
for ΔHBO2 (after removing trial 1 signals from the data), show a slightly positive correlation (the 
greater the change in oxyhemoglobin, the higher the pain score). The results based on the r 
(r=0.168) and R2 (R2 = 0.028) value show that there is no definitive correlation between fNIRS 
signal and subjects’ pain score (residual sum of squares = 210.888). 
 
 
Figure 36. Scatter plot with changes in oxyhemoglobin (channels 2, 3, 5 and 6) on the x-axis and 
pain score on the y-axis. 
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3.3.8 State Trait Anxiety Inventory Results  
 
 Effect of Stimuli via the CPT through State Anxiety Inventory score (STAI-s) State-Trait 
Anxiety Inventory Analysis (n=16) Mean displayed with standard error (SE) bars (Baseline mean 
STAI-s=26.79 +/- 1.71; Post-4˚C mean STAI-s=35.57 +/- 3.17; Post-15°C mean STAI-s=32.54 
+/- 2.40. This was identified using a two-tailed t-test for comparison.  Baseline vs. 4°C: p=0.011; 
Baseline vs. 15°C: p=0.036; Post-4˚C mean vs. Post-15°C: p=0.5016.  These results are graphically 
displayed in Figure 37. 
 
3.3.9 Short Form – McGill Pain Questionnaire Results at 4 degrees Celsius 
 
 For the case of sensory pain scores at 4 degrees Celsius, the McGill pain questionnaire 
demonstrates a significant difference between baseline pain experience and pain experienced at 
4°C (Baseline mean Sensory pain score=0 +/- 0; 4˚C Trial 1 mean sensory pain score=16.85 +/- 
1.75; 4˚C Trial 7 sensory pain score=16.85 +/- 2.01; df = 15). These results are seen in Figure 38.  
Figure 37. State trait anxiety inventory – state anxiety score comparison 
between baseline, 4 degrees Celsius and 15 degrees Celsius. 
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This was identified by using a two-tailed t-test for comparison.  Mean displayed with SE bars 
(n=16).  Baseline vs. 4˚C Trial 1: p=0.010; Baseline vs. 4˚C Trial 7: p=0.008; 4˚C Trial 1 vs. 4˚C 
Trial 7: p=1.000. 
 For the case of affective pain scores at 4 degrees Celsius, the McGill pain questionnaire 
demonstrates a significant difference between baseline pain experience and pain experienced at 
4°C (Baseline mean Affective pain score=0 +/- 0; 4˚C Trial 1 mean affective pain score=4.54 +/- 
0.75; 4˚C Trial 7 affective pain score=4.31 +/- 0.74; df = 15). These results are highlighted in 
Figure 39.  This was identified through using a two-tailed t-test for comparison.  Mean displayed 
with SE bars (n=16).  Baseline vs. 4˚C Trial 1: p=0.006; Baseline vs. 4˚C Trial 7: p=0.009; 4˚C 
Trial 1 vs. 4˚C Trial 7: p=0.489. 
For the case of total McGill Pain Questionnaire scores at 4 degrees Celsius, the McGill 
pain questionnaire demonstrates a significant difference between baseline pain experience and pain 
experienced at 4°C (Baseline mean total SF-MPQ pain score=0 +/- 0; 4˚C Trial 1 mean total SF-
MPQ pain score=21.39 +/- 1.96; 4˚C Trial 7 mean total SF-MPQ pain score=19.643 +/- 2.723; df 
= 15). These results are displayed in Figure 40.  This was identified through using a two-tailed t-
test for comparison.  Mean displayed with SE bars (n=16).  Baseline vs. 4˚C Trial 1: p=0.002; 
Baseline vs. 4˚C Trial 7: p=0.006; 4˚C Trial 1 vs. 4˚C Trial 7: p=0.435. 
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Figure 38. Short-Form McGill Pain Questionnaire – sensory pain score 
comparison between baseline, 4 degrees Celsius Trial 1 and 4 degrees 
Celsius Trial 7. 
Figure 39. Short-Form McGill Pain Questionnaire – affective pain score 
comparison between baseline, 4 degrees Celsius Trial 1 and 4 degrees 
Celsius Trial 7. 
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3.3.10 Short Form – McGill Pain Questionnaire Results at 15 degrees Celsius 
 
For the case of sensory pain scores at 15 degrees Celsius, the McGill pain questionnaire 
demonstrates a significant difference between baseline pain experience and pain experienced at 
15°C (Baseline mean Sensory pain score=0 +/- 0; 15˚C Trial 1 mean sensory pain score=8.11 +/- 
2.08; 15˚C Trial 7 sensory pain score=8.33 +/- 3.33; df = 15). Mean displayed with SE bars (n=16).  
This is seen in Figure 41.  This was identified by a two-tailed t-test for comparison.  Baseline vs. 
15˚C Trial 1: p=0.004; Baseline vs. 15˚C Trial 7: p=0.037; 15˚C Trial 1 vs. 15˚C Trial 7: p=0.901. 
For the case of the affective pain scores at 15 degrees Celsius, the McGill pain 
questionnaire demonstrates a significant difference between baseline pain experience and pain 
experienced at 15°C (Baseline mean Affective pain score=0 +/- 0; 15˚C Trial 1 mean affective 
pain score=2.22 +/- 0.98; 15˚C Trial 7 affective pain score=3.11 +/- 1.37; df = 15). Mean displayed 
Figure 40. Short-Form McGill Pain Questionnaire – total score comparison 
between baseline, 4 degrees Celsius Trial 1 and 4 degrees Celsius Trial 7. 
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with SE bars (n=16).  This is seen in figure 42. This was identified with a two-tailed t-test for 
comparison.  Baseline vs. 15˚C Trial 1: p=0.054; Baseline vs. 15˚C Trial 7: p=0.053; 15˚C Trial 1 
vs. 15˚C Trial 7: p=0.069. 
For the case of total McGill Pain Questionnaire scores at 4 degrees Celsius, the McGill 
pain questionnaire demonstrates a significant difference between baseline pain experience and pain 
experienced at 4°C (Baseline mean total SF-MPQ pain score=0 +/- 0; 15˚C Trial 1 mean total SF-
MPQ pain score=9.30 +/- 2.85; 15˚C Trial 7 mean total SF-MPQ pain score=10.30 +/- 4.35; df = 
15). Mean displayed with SE bars (n=16).  This is seen in Figure 43.  This was identified through 
using a two-tailed t-test for comparison.  Baseline vs. 15˚C Trial 1: p=0.010; Baseline vs. 15˚C 
Trial 7: p=0.042; 15˚C Trial 1 vs. 15˚C Trial 7: p=0.603. 
 
Figure 41. Short-Form McGill Pain Questionnaire – sensory pain score 
comparison between baseline, 15 degrees Celsius Trial 1 and 15 degrees 
Celsius Trial 7. 
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Figure 42. Short-Form McGill Pain Questionnaire – affective pain score 
comparison between baseline, 15 degrees Celsius Trial 1 and 15 degrees 
Celsius Trial 7. 
Figure 43. Short-Form McGill Pain Questionnaire – total score comparison 
between baseline, 15 degrees Celsius Trial 1 and 15 degrees Celsius Trial 7. 
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3.3.11 Short Form – McGill Pain Questionnaire Results Comparing 4 degrees Celsius and 
15 degrees Celsius 
 
For the case of sensory pain scores when comparing 4 degrees Celsius to 15 degrees 
Celsius, the McGill pain questionnaire demonstrates a significant difference between baseline pain 
experience and pain experienced at 4°C and 15°C respectively, and pain experienced at 4°C and 
15°C (Baseline mean Sensory pain score=0 +/- 0; 4˚C Trial 1 mean sensory pain score=16.85 +/- 
1.75; 15˚C Trial 1 mean sensory pain score=8.11 +/- 2.08; d = 15). Mean displayed with SE bars 
(n=16).  This is seen in Figure 44.  This was identified through the use of a two-tailed t-test for 
comparison.  Baseline vs. 4˚C Trial 1: p=0.001; Baseline vs. 15˚C Trial 1: p=0.001; 4˚C Trial 1 
vs. 15˚C Trial 1: p=0.001. 
For the case of the affective pain scores when comparing 4 degrees Celsius to 15 degrees 
Celsius, the McGill pain questionnaire demonstrates a significant difference between baseline pain 
experience and pain experienced at 4°C and 15°C respectively, and pain experienced at 4°C and 
15°C (Baseline mean Affective pain score=0 +/- 0; 4˚C Trial 1 mean affective pain score=4.54 +/- 
0.74; 15˚C Trial 1 mean affective pain score=2.22 +/- 0.98; df = 15). Mean displayed with SE bars 
(n=16).  This is seen in Figure 45.  This was identified through the use of a two-tailed t-test for 
comparison.  Baseline vs. 4˚C Trial 1: p=0.001; Baseline vs. 15˚C Trial 1: p=0.006; 4˚C Trial 1 
vs. 15˚C Trial 1: p=0.025. 
For the case of total McGill Pain Questionnaire scores when comparing 4 degrees Celsius 
and 15 degrees Celsius, the McGill pain questionnaire demonstrates a significant difference 
between baseline pain experience and pain experienced at 4°C and 15°C respectively, and pain 
experienced at 4°C and 15°C (Baseline mean total SF-MPQ pain score=0 +/- 0; 4˚C Trial 1 mean 
total SF-MPQ pain score=21.39 +/- 1.96; 15˚C Trial 1 mean total SF-MPQ pain score=9.30 +/- 
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2.163; df = 15). Mean displayed with SE bars (n=16).  This is seen in Figure 46.  This was identified 
through the use of a two-tailed t-test for comparison.  Baseline vs. 4˚C Trial 1: p=2.100E-4; 
Baseline vs. 15˚C Trial 1: p=0.001; 4˚C Trial 1 vs. 15˚C Trial 1: p=0.003. 
 
 
 
Figure 44. Short-Form McGill Pain Questionnaire – sensory pain score 
comparison between baseline, 4 degrees Celsius Trial 1 and 15 degrees 
Celsius Trial 1. 
Figure 45. Short-Form McGill Pain Questionnaire – affective pain score 
comparison between baseline, 4 degrees Celsius Trial 1 and 15 degrees 
Celsius Trial 1. 
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Figure 46. Short-Form McGill Pain Questionnaire – total score comparison 
between baseline, 4 degrees Celsius Trial 1 and 15 degrees Celsius Trial 1. 
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3.3.12 Results Overview 
 
First, we looked at the visual analogue scale (VAS) pain score to see how perception of 
adaptation was experienced before comparing it with the fNIRS signal.  The hypothesis here was 
that there would be a correlation between perception and the hemodynamic response.  What was 
seen is that the results were significantly different from baseline to 4°C and from 4°C to 15°C 
respectively.  There was also a significant difference between baseline pain scores and 15°C pain 
scores.  Results not shown are VAS scores from the first trial of stimulus exposure to the last trial.  
These results did not differ significantly alone from trial to trial.  This was not expected as in many 
previous studies, including studies conducted in our lab (Barati et al., 2013), when comparing 
noxious temperature perception, and innocuous temperature perception, there was a clear 
correlation between the fNIRS signal and perception.  However, when conducting the experiment 
in this investigation in a repeated measures fashion, the results do not differ from trial to trial 
significantly – proving that pain perception continues to be subjective, personalized, and easily 
influenced. (Keogh & Herdenfeldt, 2002; Loeser & Melzack, 1999; Salomons & Johnstone, 2007; 
Soetanto  J.; Wong, T., 2006) 
The simple linear regression results presented here all show that while there may be a 
correlation, that it is weak in nature and cannot definitively suggest a strong correlation with the 
fNIRS signals that are representative of all trials when compared to pain scores.  In looking only 
at trial 1 data and performing the same correlation analysis, what we see is that although the pain 
scores are rather high, this does not correlate with any level of change in oxy and deoxy 
hemoglobin, suggesting that more subjects may need to be collected.  Further, when removing trial 
1 from the analysis, the results showed the same as when trial 1 was included (no strong 
correlation); however, the correlation was even weaker, agreeing with the results of AIM 1 in that 
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trial 1 is necessary to initiate a bodily adaptation, because if there is not a significant external 
stimulus, then no adaptation is likely to show (Taylor & Taylor, 1956).  This bolsters findings 
previously identified in the literature that adaptation happens within the first few trials of repeated 
exposure experimentation when processing sensory information. (Hollins, Harper, & Maixner, 
2011)   
Regarding STAI anxiety scores, there was a significant difference between baseline and 4 
degrees Celsius as well as baseline and 15 degrees Celsius. 
When looking at sensory pain scores and total pain scores for both 4 degrees Celsius and 
15 degrees Celsius, there was a significant difference between the baseline sensory pain and the 
sensory pain score after trial 1, as well as a significant difference between the baseline sensory 
pain and the sensory pain score after trial 7.  These results were the same for the total McGill Pain 
Questionnaire scores.   
In regards to affective pain, at 4 degrees Celsius there was a significant difference between 
the baseline affective pain and the affective pain score after trial 1, as well as a significant 
difference between the baseline affective pain and the affective pain score after trial 7.  This was 
the same at 15 degrees Celsius; however, there was also a significant difference between the 
affective pain score after trial 1 and after trial 7.  
When comparing baseline McGill Pain Questionnaire scores to 4 degrees Celsius trial 1 
scores and 15 degrees Celsius trial 1 scores respectively, there was a significant difference in both 
cases regarding sensory, affective, and total scores.  This was also the case when comparing 4 
degrees Celsius trial 1 scores to 15 degrees Celsius trial 1 scores. 
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3.4 Discussion 
 
Only significant channels were carried over to this part of the analysis because the non-
significant channels did not show adaptation as defined by fNIRS (described in the discussion of 
Chapter 2).  Including the non-significant channels may skew the data, deviating from the focus 
on adaptation, so only significant channels were assessed.  In addition to this, trial 1 was included 
in all analyses performed here because based on the data from AIM 1, to observe adaptation, the 
initial exposure needs to cause a great enough change to the system that would cause a need to 
adjust back to stability.   
The information from the simple linear regression when comparing the significant channels 
from AIM 1 to the measures of perception identified in AIM 2, is informative in that while the 
autonomic response may decrease over time (adaptation), the pain score does not change in the 
same way.  The data from conducting the analysis with these specifications suggests that while the 
body physiologically adapts, the perception of the pain (being more complex (Donald, 2000)) may 
not react in the same way (Bodnar, Kelly, Spiaggia, & Glusman, 2016).  Further, additional 
subjects may be needed to increase the significance of the results shown before being able to 
definitively conclude how fNIRS compares with measures of perception. 
When looking at measures of perception alone, when comparing the two temperatures of 
4°C and 15°C, there is a great difference in perception; however, repeated exposure to the same 
temperature does not cause a change in perception that correlates with the decrease in autonomic 
response.  Thus, the hypothesis tested failed when held up to the results shown in the data.  Even 
though the results did not demonstrate a significant correlation, based on the trend that appears 
from the data, studying more subjects may strengthen the findings obtained and drive down the 
error, as well as increase the significance behind the results.   
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3.5 Conclusion 
 
The goal of the analysis conducted in this chapter was achieved in that we obtained 
results that allowed us to look at the relationship between the perceived adaptation to pain 
(perception measures) and the fNIRS signal.  The results highlighted in this chapter advanced the 
progress of the overall goal of investigating the effect of the repeated exposure experimentation 
on the hemodynamic response, because from this evaluation, when comparing the fNIRS signal 
to perception, they do not change in the same way with regard to repeated exposure 
experimentation.  This informs us that the bodies’ response may be more objective in nature than 
the response based on the awareness of an individual to their pain experience. (Bodnar et al., 
2016; Donald, 2000) 
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Chapter 4 
 
SPECIFIC AIM 3. Exploratory Analysis of fNIRS Clustering in Adaptation 
 
4.1 Introduction  
 
In machine learning, there are two groups that techniques typically fall under, supervised 
or unsupervised.  In supervised machine learning, the output is given for datasets for the creation 
of the algorithm upon training.  In unsupervised learning, there is no output given, and the goal is 
simply to be able to group the data based on the data itself.  The goal typically in unsupervised 
learning is to group together items that are “close” in a multidimensional feature space (Brock, 
Pihur, Datta, & Datta, 2008).  This gives us insight into the data itself and the separations that can 
be achieved.  One of the most common clustering methods used is hierarchical clustering where 
objects are grouped together based on distance from one another.  The complete linkage method 
was used to cluster the data here in that clusters are sequentially built on top of one another into 
larger clusters; ultimately resulting in a dendrogram with results of the hierarchy achieved in the 
clustering of the data set at hand. (Brock et al., 2008)  
What this would look like in the case of this study is being able to separate the 
hemodynamic response of specific trials into specific groups.  As adaptation should have occurred 
over repeated exposure to stimuli, the response should differ from trial to trial.  In the scope of this 
aim, the goal was to cluster the data based on trial number, following the hypothesis that there is 
a significant difference in subjects’ response based on trial to the point of easy separation through 
complete-linkage clustering.  
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4.2 Materials and Methods 
 
4.2.1 Subjects 
 
See section 2.3.2 and section 3.3.1 for details on the subject recruitment methods as these subjects 
were recruited in the same way as those in Chapter 2 and Chapter 3. 
4.2.3 Protocol 
 
See section 2.3.3 for details on protocol used as this experimental protocol followed the same 
steps as those outlined in Chapter 2. 
 
4.2.3 Measurements 
 
See section 2.3.1 and 2.3.4 for details on fNIRS measurements and analysis. 
Statistical Analysis 
 To perform the clustering analysis, the selected method was average-linkage clustering.  
Average linkage clustering can be defined as the average distance between each point in one cluster 
to points in other clusters and has recently been used by our lab to automate the process of fNIRS 
signal separation into meaningful categories (Pourshoghi, Zakeri, & Pourrezaei, 2016).  This type 
of clustering is standard to use to visualize the data.  Similar to the analysis of AIM 2, the channels 
used in this analysis are only those that demonstrated significance in AIM 1.  This would provide 
the best data for optimal clustering.  In addition to average hierarchical clustering, k-means 
clustering was also used in this exploratory analysis.  This divides clusters into groups where each 
data point congregates to a cluster with the nearest mean.  This ultimately yields to groups of data 
points that are close in value (or have the same mean). 
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4.3 Results 
 
4.3.1 fNIRS Signal Cluster Dendrograms 
 
Average linkage hierarchical clustering performed for the fNIRS signals from subjects who 
underwent the experimental process in AIM 1 for 4°C, divided into 4 distinct clusters when using 
average linkage clustering.  Figure 47 visually shows the clusters, and table 5 shows a matrix of 
accuracies based on trials.  The channels of significance for oxyhemoglobin (channels 2, 3, 5 and 
6) and deoxyhemoglobin (channels 3, 5 and 6) were used for this analysis.  What this shows is 
how well the clustering algorithm could differentiate between different trials.  From the data in 
Table 5, while trials 3, 4 and 5 seem to gather in cluster 2 with a higher percentage, there is no 
apparent dominance of any trial in any cluster.  
 
 
 
Figure 47. Average clustering analysis using channels 3, 5 and 6 from the change in 
deoxyhemoglobin and channels 2, 3, 5 and 6 from the change in oxyhemoglobin; cluster 
1 begins on the left and the subsequent trials follow sequentially ending with cluster 4 
being the rightmost cluster. 
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Cluster 1 Cluster2 Cluster 3 Cluster 4 Cluster 5 Cluster 6 Cluster 7 
Trial 1 0.00% 25.00% 0.00% 0.00% 50.00% 25.00% 0.00 
Trial 2 20.00% 20.00% 10.00% 0.00% 0.00% 40.00% 10.00 
Trial 3 9.09% 18.18% 9.09% 9.09% 27.27% 18.18% 9.09 
Trial 4 8.33% 16.67% 8.33% 0.00% 25.00 25.005 16.67 
Trial 5 0.00% 16.67% 0.00% 0.00% 8.33% 66.67% 8.33 
Trial 6 0.00% 15.38% 7.69% 7.69% 15.38% 30.77% 23.08 
Trial 7 0.00% 30.77% 15.38% 7.69% 15.38% 30.77% 0.00 
Table 5. Matrix of accuracies from average clustering performed in Figure 47. 
 
 To further see if the data can be grouped appropriately, the channel with the greatest 
significance (channel 5 in the case of oxy and deoxyhemoglobin) was used to perform the 
clustering analysis.  Similar to the results seen in Figure 47 and Table 5, Figure 48 and Table 6 
do not show that any trial is more dominant in any of the clusters. 
 
 
 
 
Figure 48. Average clustering analysis using channel 5 from the change in 
deoxyhemoglobin and channel 5 from the change in oxyhemoglobin; cluster 1 is the 
leftmost cluster with the clusters following sequentially ending with cluster 5 being the 
rightmost cluster. 
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Cluster 1 Cluster2 Cluster 3 Cluster 4 Cluster 5 Cluster 6 
Trial 1 42.86% 14.29% 0.00% 0.00% 0.00% 42.86% 
Trial 2 9.09% 9.09% 9.09% 18.18% 27.27% 27.27% 
Trial 3 9.09% 18.18% 9.09% 9.09% 18.18% 36.36% 
Trial 4 7.69% 15.38% 0.00% 7.69% 38.46% 30.77% 
Trial 5 7.14% 14.29% 0.00% 7.14% 64.29% 7.14% 
Trial 6 8.33% 8.33% 0.00% 33.33% 33.33% 16.67% 
Trial 7 15.38% 15.38% 7.69% 0.00% 38.46% 23.08% 
Table 6. Matrix of accuracies from average clustering performed in Figure 48. 
 
As this analysis was an exploratory analysis, k-means clustering was also used to see if 
any information could be obtained by setting the number of clusters that the data should be 
divided into.  Table 7 shows the k-means clustering analysis performed for the fNIRS signals 
from subjects who underwent the experimental process in AIM 1 for 4°C, with a cutoff of two 
clusters.  Table 7 shows the matrix of accuracies based on trials.  The channels of significance 
for oxyhemoglobin (channels 2, 3, 5 and 6) and deoxyhemoglobin (channels 3, 5 and 6) were 
used for this analysis.  What this shows is how well the clustering algorithm could differentiate 
between different trials.  From the data in Table 7, while trials 1 and 5 seem to have a high 
percentage of data gathering in cluster 1, there is no apparent pattern that is observed with 
regards to specific trials (early or late) belonging to specific clusters. 
 
Cluster 1 Cluster 2 
Trial 1 81.82% 18.18% 
Trial 2 41.67% 58.33% 
Trial 3 69.23% 30.77% 
Trial 4 69.23% 30.77% 
Trial 5 92.31% 7.69% 
Trial 6 58.33% 41.67% 
Trial 7 69.23% 30.77% 
Table 7. Matrix of accuracies from k-means clustering (cutoff set at 2 clusters) using channels 3, 
5 and 6 from the change in deoxyhemoglobin and channels 2, 3, 5 and 6 from the change in 
oxyhemoglobin. 
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Table 8 shows the matrix of accuracies based on trials as well using k-means clustering, 
however the cutoff here was set at 7 trials.  The channels of significance for oxyhemoglobin 
(channels 2, 3, 5 and 6) and deoxyhemoglobin (channels 3, 5 and 6) were used for this analysis.  
Similar to the data from table 7, there is no apparent pattern that is observed with regards to 
specific trials (early or late) belonging to specific clusters. 
 
Cluster 1 Cluster 2 Cluster 3 Cluster 4 Cluster 5 Cluster 6 Cluster 7 
Trial 1 9.09% 9.09% 18.18% 18.18% 27.27% 0.00% 18.18% 
Trial 2 0.00% 16.67% 8.33% 16.67% 16.67% 25.00% 16.67% 
Trial 3 0.00% 15.38% 15.38% 38.46% 23.08% 0.00% 7.69% 
Trial 4 0.00% 7.69% 38.46% 15.38% 23.08% 7.69% 7.69% 
Trial 5 0.00% 23.08% 0.00% 15.38% 30.77% 15.38% 15.38% 
Trial 6 8.33% 0.00% 16.67% 33.33% 16.67% 0.00% 25.00% 
Trial 7 7.69% 0.00% 0.00% 38.46% 30.77% 15.38% 7.69% 
Table 8. Matrix of accuracies from k-means clustering (cutoff set at 7 clusters) using channels 3, 
5 and 6 from the change in deoxyhemoglobin and channels 2, 3, 5 and 6 from the change in 
oxyhemoglobin. 
Furthering these two analyses, the k-means clustering was repeated, using only the most 
significant channel in the case of deoxyhemoglobin (channel 5) and oxyhemoglobin (channel 5).  
Results of this are seen in table 9 and table 10.  In both cases, even though majority of cases tend 
to congregate to cluster 2, there is no apparent pattern that would identify that the data were 
significantly different enough to be separated through clustering. 
 
Cluster 1 Cluster 2 
Trial 1 27.27% 72.73% 
Trial 2 41.67% 58.33% 
Trial 3 38.46% 61.54% 
Trial 4 23.08% 76.92% 
Trial 5 23.08% 76.92% 
Trial 6 16.67% 83.33% 
Trial 7 46.15% 53.85% 
Table 9. Matrix of accuracies from k-means clustering (cutoff set at 2 clusters) using channel 5 
from the change in deoxyhemoglobin and channel 5 from the change in oxyhemoglobin. 
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Cluster 1 Cluster 2 Cluster 3 Cluster 4 Cluster 5 Cluster 6 Cluster 7 
Trial 1 18.18% 9.09% 0.00% 27.27% 9.09% 18.18% 18.18% 
Trial 2 16.67% 16.67% 8.33% 25.00% 16.67% 8.33% 8.33% 
Trial 3 23.08% 15.38% 0.00% 30.77% 15.38% 15.38% 0.00% 
Trial 4 7.69% 7.69% 30.77% 0.00% 15.38% 38.46% 0.00% 
Trial 5 15.38% 7.69% 23.08% 15.38% 7.69% 30.77% 0.00% 
Trial 6 0.00% 0.00% 41.67% 8.33% 8.33% 33.33% 8.33% 
Trial 7 0.00% 23.08% 7.69% 30.77% 15.38% 23.08% 0.00% 
Table 10. Matrix of accuracies from k-means clustering (cutoff set at 7 clusters) using channel 5 
from the change in deoxyhemoglobin and channel 5 from the change in oxyhemoglobin. 
 
4.4 Discussion 
 
In the brief exploratory analysis conducted in this investigation to better visualize the data, 
the results from the clustering analysis do not show any definitive differentiation between trials 
when it comes to grouping the data.  This can be interpreted to mean that the hemodynamic 
response from any specified trial (trial 1, trial 2, trial 3, etc.), was not specific enough to allow the 
clustering algorithm to train on the data and efficiently separate it.  This suggests that the changes 
after initial exposure to a stimulus are subtle.  Identifying two different processes, fast (initial) 
adaptation, and the subsequent fine tuning that occurs during repeated exposure to bring the body 
back to stability (Hollins et al., 2011).   The rationale for this could include several different things.  
First, as there were only a small number of subjects (n=15), there may not be enough data for the 
algorithm to appropriately train on, and thus separate the data.  More subjects would help to drive 
up the significance, or in the case of clustering, dominance of specific trials in specific clusters 
would be shown.   Secondly, there may need to be more preparation of the data prior to clustering.  
Using functional data analysis before clustering separation may create a better “definition” of what 
each trial should look like and better inform the clustering (Pourshoghi et al., 2016; Tak & Ye, 
2014).  Thirdly, adding additional features and using recursive feature extraction will not only 
focus on significance, but it will have a greater number of features to choose from (Pourshoghi et 
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al., 2016). Adding this analysis prior to the clustering will give a greater number of features to test 
from, providing more opportunities for the algorithm find efficient biomarker features for trial 
separation.  
The hypothesis that earlier trials would be separated from later trials failed.  This was 
unexpected given that based on the results from AIM 1, trial 1 impacted the hemodynamic response 
enough to change the significance of the data when removed from analysis.  If this is the case, we 
at minimum would have expected trial 1 data to be grouped together.  With this not being the case, 
further studies should be conducted with more subjects.  This would show if it is simply more data 
that is needed for clustering to be done appropriately, or if other unsupervised machine-learning 
techniques should be used for automated data separation.  In interpreting these results, the goal to 
separate the data into groups based on trials was not achieved, but more information about the 
data, subject number, and quality of the information, can inform future studies to better understand 
how to separate the data.   
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Chapter 5 
 
5.1 Summary 
 
Pain is one of the least well understood phenomena in modern medicine (Råheim & Wench, 
2006).  There are several components to it that make it difficult to understand.  In one regard, pain 
is the result of some external event.  From the external event, when the body’s defense system 
goes into action, pain is part of the healing process that allows the body to repair the damage that 
is done.  Pain can also be the result of neuronal degradation or physiological changes in the body, 
that do not necessarily occur as the result of external happenings.  Further, there is the emotional 
component of pain to also consider (Phillips et al., 2003).  Given these differences, it is difficult to 
find the appropriate tool to use in clinical settings when treating patients with pain.  In the last 
couple of decades, with the advancements in technology as well as data analysis improvements, 
there has been a paralleled increase in research done in the field of pain; furthermore, as non-
invasive modalities become the standard in medicine, imaging modalities have led the field in 
breakthroughs when it comes to measuring pain.  There have been a series of goals that each of 
these modalities attempt to achieve, and this has led pain research to where it is today.   
One of these goals is to find biomarkers (Borsook, 2011) that are coupled with the body’s 
pain response.  Biomarkers, like their name suggests, are markers in the biological make up of 
individuals that are linked with physiological processes.  Their importance is in their linkage, 
because the linkage allows different physiological processes to be followed, monitored, and 
appropriately treated when something goes wrong.  Without these in place, it would make treating 
bodily ailments more difficult, but taking this approach to investigating pain is one of the first 
steps in finding physiological features, that are best situated to aide physicians in diagnosing and 
treating pain. 
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In the first study conducted in this analysis in AIM 1, the study had the goal of measuring 
the hemodynamic response to noxious and innocuous stimuli, using the biomarkers of changes in 
oxy and deoxyhemoglobin.  In using multilevel modeling to fit a model that estimates the change 
over time to repeated exposure, as expected, in the case of 4 degrees Celsius over 7 trials for 
deoxyhemoglobin, 67% of the channels showed a significant reduction in magnitude over time to 
the stimulus presented.  Upon removing the first trial and conducting the same analysis, it became 
apparent that the initial exposure greatly influences adaptation and is where the majority of 
adaptation occurs (only 17% of channels showing significant reduction in response over time).  
For 4 degrees Celsius result for oxyhemoglobin, 50% of the channels demonstrated a significant 
reduction in response over time through using multilevel modeling.  Overall, informing us that 
while adaptation does occur when exposed to a stimulus repeatedly, in future works, one may 
consider focusing on select channels of interest.  This continues to further expand upon the studies 
that aim to identify useful biomarkers for monitoring pain.   
The results of AIM 2 showed the utility of these biomarkers in how they compared to the 
perception of pain.  In looking at correlating pain scores to trial number in AIM 2, linear regression 
showed that while there was a trend in the data that the greater the change in oxy or 
deoxyhemoglobin, the higher the pain score.  This warrants further studies with greater subject 
numbers to see if significance in the trend of the data can be obtained.  While hemodynamics in 
the prefrontal cortex region may be a robust biomarker for objectively monitoring pain, there is 
not a direct relationship between perceived adaptation and the objective response – highlighting a 
difference between the physical pain experience, and the behavioral component encompassing 
pain perception.  
105 
 
An additional goal for improving the utilities of these modalities in monitoring pain is 
finding an effective method of using the biomarkers identified in the first goal.  While this may 
seem intuitive, several factors are taken into consideration – combining the data collected using 
the fNIRS system, with different modes of analyzing this data.  This was at the center of the 
exploratory analysis of AIM 3.  The focus here was on clustering the data, and in performing this 
analysis, no significant results were revealed.  The table of matrices show that the hemodynamic 
change differences between trials was not enough for clustering to separate the data into trial 
groups.  Similar to the results from AIM 2, this suggests that more subjects should be studied with 
more data to refine the results.   
Our measurements based on near infrared spectroscopy (fNIRS) are in support of the idea 
that objective biomarkers can be obtained from the fNIRS signal.  Not only this, but previous 
studies in our lab, such as initially investigating fNIRS and its ability to monitor the response to 
pain (Barati et al., 2013), and even further investigating how this data can be useful in a clinical 
setting through automating the results into useful information (Pourshoghi et al., 2016), in 
conjunction with previous literature and results shown here, show that repeated exposure to 
noxious stimuli results in adaptation.   
The results discussed throughout this thesis suggest the use of the fNIRS imaging modality 
to objectively assess the adaptation to stimuli from repeated exposure.  Based on the use of fNIRS 
in the prefrontal cortex region, measurements of the relative change of oxy and deoxyhemoglobin 
over time were explored to investigate the change over time that occurs as a result of repeated 
exposure.  When presented with a strong enough initial stimulus, we saw that adaptation was 
readily observable, and continued steadily as repeated trials were employed.  Comparing this with 
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an initial stimulus that is not painful yielded results that showed no adaptation, suggesting that if 
there is not a strong enough initial stimulus, there is no adaptation to occur. 
Based on these findings and in looking at the other measures of perception taken (State 
Trait Anxiety Inventory and McGill Pain Questionnaire), it suggests that fNIRS may be a 
promising tool to observe adaptation over time, and that there are clear trends of how the fNIRS 
signal relates to measures of perception; moreover, it suggests that initial exposure plays a key role 
in adaptation over time to a stimulus. 
 
5.2 Future Work 
 
While there has been an increased level of interest in fNIRS in regards to the monitoring 
of pain, there is still a great amount of work to be done.  Many of the technologies that provide 
accurate information for ailment diagnosis such as positron emission tomography (PET), single 
photon emission computed tomography (SPECT), computerized tomography (CT), and magnetic 
resonance imaging (MRI) are extremely effective in tracking biomarkers for pain as well as 
identifying which body parts are impacted by the pain response.  Despite their accuracy however, 
these systems are lacking in their ease of use.  Each of the systems identified above are extremely 
expensive for hospitals or clinics to obtain, and even more, to run tests using these systems costs 
an exorbitant amount of money.  Thus, these shortcomings have given way to other modalities that 
provide similar information, but are more cost effective and can be used routinely in a clinical 
setting.  Tools such as ultra sound, laser dopplar flowtometry, and near infrared spectroscopy have 
gained traction in the field of pain research.  One of the problems however is that these devices 
are initially not able to provide the same quality of information, which has caused a growth in 
improving the data processing of the information provided by these modalities post-use.  As a 
result, the majority of the work until now has focused on the feasibility of using fNIRS to assess 
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relative pain experienced, the analysis of the data, as well as generating algorithms through 
machine learning processes to get one step closer to use of fNIRS in a clinical setting.  
Improvements that can be made upon the work done thus far include: 
Phantom limb pain (or similar pain experiences) – When observing phantom limb pain, 
there is no observable physical component to the pain, but rather a psychological component.  
Seeing if fNIRS can readily be used as a tool in this regard would prove that it is not limited to 
physical pain experiences but also psychological pain experiences.  This would be an expansion 
of the work discussed in this thesis as well as other works surrounding the perception of pain. 
Multi-distance optode analysis – Many studies with fNIRS that use multi-distance 
detectors (near versus far), place greater emphasis on the reliability of the far detectors that 
penetrate to the cortical tissue, versus the near detector which encompasses the signal from the 
skin response.  Not much is known about how the skin response influences the signal.  Using 
techniques such as principal component analysis or independent component analysis will yield a 
greater understanding of the information received by the far detectors and how to improve signal 
quality. 
5.3 Clinical Applications 
 
The investigation highlighted in the scope of this thesis surrounding the adaptation to repeated 
exposure to stimuli can have impact in the clinical settings in the following ways: 
• When dealing with patients who have mild to chronic pain problems, understanding how 
they adapt to pain can give information on how to appropriately treat the pain.  If patients 
adapt well to pain, the problem may not lie solely in the pain receptors (for chronic pain 
patients these receptors often stay activated continuously), but rather physicians may 
explore other treatment options to yield a more evidence based approach to practicing pain 
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management medicine. (Hirsch, Charpie, Ohye, & Gurney, 2010; Obrig, 2014; Smith, 
2011) 
• This also suggests how fNIRS can be used as a diagnostic tool in that the scope of this 
research included healthy individuals who react appropriately to pain.  If in the clinic, an 
otherwise healthy person undergoes this same test and does not adapt to pain after exposure 
to noxious stimuli as was seen throughout the results in this thesis, this could be an indicator 
in that their body does not react to pain in a healthy manner.  Why this is important is that 
pain is a phenomenon that our body needs to let us know when we are in danger or 
experiencing an unusual change to our system. 
• With the size, mobility and robustness of the fNIRS system, it can readily be used in a 
clinical setting with fast and reliable results, which is why the research here, as well as 
continuing research in applying fNIRS to pain brings us closer and closer to having fNIRS 
as an aide in the diagnosis and treatment of pain. 
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